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The Role of Somatostatin in the Regulation of Gonadotropin Secretion in Sheep 
 
Two modes of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) 
secretion are necessary for female fertility: surge and episodic secretion. However, the neural 
systems that regulate these GnRH secretion patterns are still under investigation. The 
neuropeptide somatostatin (SST) inhibits episodic luteinizing hormone (LH) secretion in humans 
and sheep, and several lines of evidence suggest SST may regulate secretion during the LH 
surge. Neither a SST receptor 2 (SSTR2) agonist (octreotide) or antagonist (CYN154806; CYN) 
altered the amplitude or timing of the LH surge. Administration of CYN to intact ewes during 
either the breeding season or anestrus increased LH secretion and increased c-Fos in a subset of 
GnRH and kisspeptin cells during anestrus. To determine if these stimulatory effects are steroid-
dependent or -independent, we administered CYN to ovariectomized ewes. This SSTR2 
antagonist increased LH pulse frequency in ovariectomized ewes during anestrus, but not during 
the breeding season.  The results demonstrate that SST, acting through SSTR2, inhibits episodic 
LH secretion, likely acting in the mediobasal hypothalamus, but action at this receptor does not 
alter LH surge secretion. Additionally, these data provide evidence that SST contributes to the 
steroid-independent suppression of LH pulse frequency during anestrus. 
 
Potential sites for SST action in the ovine hypothalamus were investigated using 
immunohistochemistry to determine whether cells that produce kisspeptin (KNDy cells in the 
arcuate nucleus) or GnRH receive direct synaptic contact from SST fibers, and whether the 
amount of these inputs changes throughout the estrous cycle or by season. The majority of 
KNDy cells receive synaptic input (evident by presynaptic synaptophysin immunostaining) from 
 
 
SST cells, but the amount of these inputs did not differ among groups. A subset of GnRH cells in 
both the preoptic area (POA) and mediobasal hypothalamus also receive synaptic input from 
SST cells. A greater percentage of POA GnRH cells had SST synapses during the surge than in 
anestrus, the luteal or early follicular phase of the estrus cycle. The total number of synaptic 
inputs onto GnRH and KNDy cells was altered by phase of the estrous cycle and season, 
extending the hypothesis that changes in the GnRH and KNDy cell synaptic connectivity may 
contribute to altered gonadotropin secretion throughout the estrous cycle and between seasons. 
Several lines of evidence support the hypothesis that somatostatin (SST) cells in the 
ventral medial nucleus (VMN) may be involved in the generation of the LH surge in sheep. In 
this study, we confirmed that SST cells in the VMN are activated during the LH surge using c-
Fos as a marker for cellular activation. One explanation for the discrepancy between the 
observations of SST cell activation during the LH surge, but no effect of pharmacological 
manipulation of SSTR2, is that the cells that contain SST in the VMN also produce additional 
signaling molecules, such as nitric oxide. We used immunohistochemistry to determine that a 
high percentage (70-80%) of these SST cells also contain neuronal nitric oxide synthase (nNOS). 
Triple-label immunohistochemistry was used to determine that a greater percentage of the dual 
labeled SST and nNOS cells contain c-Fos during the LH surge compared to the early follicular 
phase. In contrast, the percentage of single labeled nNOS or SST cells that contained c-Fos did 
not differ between the LH surge and early follicular phase. Thus we propose that this population 
of SST cells in the VMN also release nitric oxide and that this transmitter contributes to the 
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The potential for female fertility is manifest through reproductive cyclicity. Menstrual or 
estrous cycles are neural and endocrine phenomena that synchronize the necessary processes for 
fertility: 1) production and release of ova, 2) preparation of the reproductive tract for fertilization 
and implantation, and 3) reproductive behavior. Reproductive cycles are named based on 
observable signs. In female humans and primates the inner layers of the endometrium, are 
sloughed off and flows out through the vagina as 35mL (on average) of thick blood and cellular 
mixture, in a process termed menstruation and thus the reproductive cycles in these species are 
termed “menstrual cycles.” In most other species, however, menstruation does not occur, instead 
the outward sign is altered behavior, which varies by species but is generally aimed at attracting 
and/or receiving a mate and only occurs around the time of ovulation, termed estrous behavior, 
and thus in these species, reproductive cycles are termed “estrous cycles.”  
The term gonadotropin will be used extensively; this term refers to hormones that affect 
change in the gonads, which are endocrine glands. The endogenous gonadotropins in sheep are 
luteinizing hormone (LH) and follicle stimulating hormone (FSH). Two additional molecules 
isolated from other species are experimentally relevant: human chorionic gonadotropin (hCG) 
and pregnant mare serum gonadotropin (PMSG), which have LH-like and FSH-like activities, 
respectively.  
The current model for the estrous cycle in sheep posits that follicular development 
requires sequential treatment with FSH and then with LH. The growing follicle(s) produce low 
amounts of estradiol (E2) which exerts a negative feedback effect to maintain low gonadotropin 
releasing hormone (GnRH) and LH secretion from the hypothalamus and pituitary gland, 
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respectively. Increased LH pulse frequency stimulates further E2 production and final stages of 
follicular development. When the viable follicle(s) secrete enough E2, positive feedback action at 
the hypothalamus and pituitary ensues stimulating a surge secretion of GnRH and LH. The 
GnRH and LH surge is characterized by very high and sustained release of these hormones. The 
LH surge stimulates resumption of meiosis, final development of the ovum and ovulation. The 
high concentrations of E2 also causes estrous behavior. The ovulated ovum and attached 
granulosa cells, together called the cumulus oocyte complex, are ejected from the ovary, 
collected by the infundibulum and transported through the oviducts toward the uterus. The 
remaining granulosa and theca cells from the ovulated follicle undergo luteinization (also 
induced by the LH surge)  to  transform into luteal cells which form the corpus luteum (CL), a 
transient structure on the ovary that produces progesterone (P4), and in some species, also E2. 
Progesterone potently inhibits GnRH, and LH release, and also acts on the reproductive tract to 
suppress myometrial contractions and stimulate fluid secretion from the endometrium. In the 
absence of a pregnancy, the CL functionally (based on P4 secretion) and structurally regresses 
though a combination of apoptosis and necrosis. In the absence of inhibitory actions of P4, 
gonadotropin concentrations again rise, stimulating follicular growth and allow the cycle to 
repeat. 
Reproductive cycles can be divided in two phases based on the dominant structure on the 
ovary: follicle(s) (follicular phase) or CL (luteal phase). The average estrous cycle length in 




OVARIAN FUNCTION THROUGHOUT THE ESTROUS CYCLE 
 
In sheep, follicular development occurs throughout the estrous cycle. Primordial follicles 
that are formed during gestation and are maintained in a quiescent state until recruitment (1). 
Primordial follicles consist of single oocyte surrounded by a single layer of approximately 4 
flattened granulosa cells (2). Almost all of the 100,000-250,000 follicles present at birth will 
regress by atresia continuously throughout life (3). Follicular development can be divided into 
stages based on structure of the growing follicle. The first stage of follicular growth is the 
formation of primary follicles from the primordial pool. These follicles grow into primary 
follicles by granulosa cell proliferation (~19 cells per follicle) and transition to cuboidal cell 
morphology (2). Follicular growth in the preantral stage continues by proliferation of granulosa 
cells, emergence and proliferation of theca interna cells, and  development of the zona pellucida 
(2). The next observable stage in follicle development is formation of a fluid filled antrum, 
which will grow in size as the follicle matures into a preovulatory follicle.  
Follicular growth can also be divided into stages based on signals that stimulate follicular 
growth. Hypophysectomized ewes developed follicles up to 2 mm in diameter, indicating an 
initial phase of gonadotropin-independent follicular growth (4). Growth of follicles larger than 2 
mm in hypophysectomized ewes has been achieved by administration of PMSG and growth 
hormone (5), indicating a later gonadotropin sensitive phase of growth. Granulosa cells contain 
mRNA for FSH receptor (6) and bind radio-labeled FSH (7) beginning in the early preantral 
stage (as soon as two layers of cuboidal cells appear), and continuing throughout follicular 
development or advanced atresia. As follicles continue to grow, one to three follicles are selected 
for continued growth and the remaining follicles become atretic. Follicles, particularly granulosa 
cells produce the protein hormone inhibin (8,9) that accumulates in follicular fluid (10) and 
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circulates in concentrations proportional to follicular growth (11). Inhibin acts synergistically 
with E2 on the gonadotropes of the anterior pituitary gland to suppress FSH secretion (8,12) but 
not LH secretion (13–16). FSH deprivation induces atresia in the smaller follicles, which can be 
reversed with administration of PMSG (17). The larger follicle(s) are instead supported by LH, 
because there is a robust increase in LH receptor content in granulosa cells in follicles 4-6mm in 
diameter compared to smaller follicles as detected by radio-ligand binding (7). In sheep, there is 
weak evidence for follicular dominance as described in other species (18). Instead the cohort of 
growing follicles is likely thinned to the ovulatable follicle(s) by atresia in smaller follicles that 
do not contain LH receptor. Early follicular growth is dependent on FSH, but after achieving 
some growth these follicles require high frequency LH pulses to grow to into ovulatory follicles 
(19).  
Some, but not all reports have described the pattern of follicular development as wave-
like, such that 2-3 ‘waves’ of follicle development, each 5-6 days long, occur each cycle (3,20–
23). During each wave a cohort of follicles is recruited, from this pool a few (one to three) 
growing follicles are selected with the remaining follicles regressing through atresia (24). During 
the terminal follicular wave of the estrous cycle, the dominant follicle(s) will continue to develop 
until ovulation, during other waves, these follicles will become atretic (25). 
An important function of the growing follicles is E2 production. Androgens are produced 
in the theca cells which diffuse into the granulosa cells that contain aromatase, which is 
necessary for production of E2. Synthesis of E2 is stimulated by pulsatile LH secretion (26); 
pulses of E2 are observable following pulses of LH (27). Steroid synthesis likely commences just 
prior to antrum formation with the induction of the essential enzymes for androgen production 
(steroid acute regulatory protein, P450 side chain cleavage, 17α-hydroxylase and 3β 
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hydroxysteroid dehydrogenase) in the theca cells and aromatase in granulosa cells (28). 
Synthesis of E2 increases with follicle development and follicle diameter is correlated with 
follicular fluid E2 concentrations (20). 
The ovulatory cascade is initiated by increased cAMP in theca and granulosa cells 
induced by surge secretion of LH. Ejection of the oocyte is accomplished by enzymatic 
degradation of the ovarian stroma involving matrix metalloproteases and collagenases (29) and 
an increase in follicular pressure caused by hyperemia and smooth muscle contraction (30). The 
preovulatory rise in LH also stimulates urokinase-type plasminogen activator in the ovarian 
epithelium which targets enzymatic degradation to the apical follicular wall resulting in stigma 
formation and ultimately rupture (31,32). In oocytes, the LH surge reduces cAMP which allows 
the resumption of meiosis in preparation for fertilization (33).  
Following ovulation, theca and granulosa cells are transformed into the small and large 
luteal cells that form the CL (34). Development of the CL is associated with marked changes in 
cell function and vascularization of the tissue. In ruminants, large luteal cells constitutively 
produce P4, whereas LH stimulates P4 secretion from small luteal cells via activating 
phosphorylation of steroid acute regulatory protein (35). In sheep, the CL is maintained by LH 
and growth hormone (36).  
The luteal phase is terminated with the regression of the CL, which is caused by uterine 
derived prostaglandin F2α secretion in sheep (37–39). The luteolytic properties of prostaglandin 
F2α are mediated by multiple pathways including intra-luteal production of oxytocin (40), 
reduced blood flow (41), reduced P4 synthesis (42), and induction of apoptosis (43). Ultimately 
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functional (cessation of P4 production) and structural (remodeling of the CL tissue) demise of the 
CL occurs.   
HYPOTHALAMIC REGULATION OF THE ESTROUS CYCLE 
HYPOTHALAMIC ANATOMY 
 
The major neuro-circuits that regulate steroid feedback mechanisms necessary for the 
estrous cycle reside in the hypothalamus.  Other brain regions also participate in regulation of 
reproduction and sensing or mediating extrinsic and intrinsic signals that are ultimately 
integrated in the hypothalamus, including the brainstem, amygdala, and pineal gland. The 
hypothalamus is located in the basal portion of the diencephalon, above the pituitary gland and 
below the thalamus. The hypothalamus consists of numerous nuclei, which are clusters of 
neuronal soma, that are typically named for their location. The major regions important for 
regulation of reproduction include the arcuate nucleus (ARC), the ventral medial nucleus 
(VMN), the retrochiasmatic area (RCh), and the preoptic area (POA). The mediobasal 
hypothalamus (MBH) is a larger region encompassing the ARC, VMN, RCh and surrounding 
areas; as the name implies it is located in the ventral medial region of the hypothalamus. The 
median eminence is located beneath the third cerebral ventricle (3V) at midline and is the site of 
the primary capillary bed of the hypothalamic-pituitary portal system, which carries 
neurohormones produced in the hypothalamus to their site of action in the anterior pituitary 
(Figure 1). 
The ARC is located in the ventral medial portion of the hypothalamus near the 3V and 
above the median eminence. This nucleus extends in the rostral-caudal direction a considerable 
distance and is often divided into rostral, middle and caudal portions. In sheep, common criteria 
8 
 
for the division between the anterior and middle ARC is the rostral aspect of the tubero-
infundibular sulcus. The middle and caudal ARC are often separated at the rostral portion of the 
mammillary recess. The VMN is located dorsal to the ARC and medial to the fornix (a large 
fiber tract connecting the hippocampus and mammary bodies). The RCh is located just caudal to 
the optic chiasm at the ventral aspect of the hypothalamus. The POA is located in the brain 
directly above the optic chiasm, surrounding the rostral portion of the 3V. 
In sheep, neurons that produce GnRH are distributed throughout the hypothalamus, the 
four major populations are in diagonal band of Broca, POA, anterior hypothalamic area (located 
between the POA and MBH) and in the MBH (44). The external zone of the median eminence 
contains a dense plexus of GnRH containing fibers where GnRH is released into the portal blood. 
Figure 1: Sagital section of the ovine hypothalamus. POA, preoptic area; OCh, optic chiasm; 
RCh, retrochaismatic area; VMN, ventral medial nucleus; ARC, arcuate nucleus; ME, median 













PULSATILE SECRETION OF LH  
 
Throughout much of the estrous cycle (and in OVX ewes) LH is secreted from the 
anterior pituitary in a pulsatile pattern (45) in response to pulsatile secretion of GnRH from the 
hypothalamus (46). During the breeding season, E2 suppresses LH pulse amplitude whereas P4 
suppresses LH pulse frequency (47). Suppression of pulse amplitude by E2 is mediated within 
the hypothalamus, evident by a decrease in GnRH pulse amplitude (48), and in the pituitary 
gland by reducing the sensitivity to GnRH (47). The ability of P4 to suppress pulse frequency 
requires recent E2 exposure (49), which increases P4 receptor content within the hypothalamus in 
numerous species (50–54). Throughout most of the estrous cycle, E2 and P4 suppress LH 
secretion and is referred to as ‘negative feedback.’ 
The organized episodic pattern of GnRH and LH release has led to the concept of a pulse 
generator to develop and synchronize discrete pulses of GnRH release. Several lines of evidence 
support the hypothesis that the GnRH pulse generator is located in the MBH in sheep. Neural 
deaffferentiation immeidatly caudal to the optic chiasm or POA did not disturb pulsatile pattern 
of LH secretion (55). However, cuts through the ARC did ablate the pulsatile pattern of LH 
secretion indicating that pulse generation does not require input from rostral areas but neuronal 
connections within the MBH are essential for generation of pulses. Further evidence that the 
GnRH pulse generator is located in the MBH comes from the report that bursts in multi-unit 
activity recorded in the MBH are highly correlated to LH secretion events (56). 
a. THE KNDy HYPOTHESIS FOR GnRH PULSE GENERATION 
The current prevailing model for generation of GnRH pulses involves paracrine and 
autocrine actions of neurons in the ARC that contain the peptides: kisspeptin, neurokinin B 
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(NKB), and dynorphin (Dyn) and the steroid receptors: ERα (57) and progesterone receptor (58). 
A role for kisspeptin signaling in the regulation of reproduction was identified by genetic 
screening in humans with hypogonadotropic hypogonadism. Some of these patients were found 
to harbor mutations in the gene encoding the receptor for kisspeptin (GPR54 or Kiss1R) (59,60). 
Subsequent studies have identified mutations in the kiss1 gene (which encodes kisspeptin) that 
cause hypogonadotropic hypogonadism (61) and activating mutations in the Kiss1R gene that are 
associated with precocious puberty (62). There are two populations of hypothalamic kisspeptin 
containing cells: a large population in the ARC and a smaller population in the POA. In sheep 
and primates, the kisspeptin cells are scattered in the preoptic area, whereas in rodents these cells 
are more densely arranged in the rostral periventricular region of the third ventricle (RP3V). 
Kisspeptin or Kiss1R knock-out mice have small gonads and low gonadotropin concentrations 
(59,63). In sheep, iv (64,65) or icv (66) kisspeptin injection increased GnRH and LH secretion 
and icv infusion of a Kiss1R antagonist inhibited pulsatile LH secretion (65). Neurokinin B is 
expressed in the mediobasal hypothalamus and icv injection of NKB (67,68) or neurokinin 
receptor 3 (NK3R) agonist (senktide) (66,67,69) also stimulated LH secretion in sheep. 
Conversely, antagonists to NK3R inhibited pulsatile LH secretion in sheep when administered 
into the lateral ventricle (66) or placed directly into the ARC (70). Similar to kisspeptin, 
mutations in the genes that encode NKB and NK3R cause hypogonadotropic hypogonadism in 
humans (71). The endogenous opioid peptide Dyn acts via the κ-opioid receptor (KOR) to inhibit 
LH secretion and is critical for P4 negative feedback (72).  
Several groups independently proposed a model for pulse generation in which NKB is 
first released and acts on KNDy cells to stimulate kisspeptin release, dynorphin is subsequently 
released and acts to inhibit kisspeptin release. In this model kisspeptin is the output signal from 
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the KNDy neurons which acts on GnRH neurons to stimulate GnRH and LH release during a 
pulse (73–77). Kisspeptin is released in the median eminence in a pulsatile pattern that is highly 
correlated with GnRH release in monkeys (78). Administration of NKB or an antagonist to KOR 
increased, and dyn inhibited volleys of multi-unit activity recorded in the ARC and LH pulses in 
goats (74). Kisspeptin administration increased LH secretion, but did not alter multi-unit activity, 
which was interpreted to indicate that kisspeptin acts downstream of the pulse generator to 
stimulate GnRH release. GnRH cells in both the POA and MBH as well as GnRH fibers in the 
median eminence receive inputs from kisspeptin containing fibers (77,79) furthermore GnRH 
cells in the POA contain mRNA for Kiss1R in sheep (65).  
KNDy cells are part of a highly interconnected network in which KNDy cell soma 
receive synaptic input from KNDy peptide containing fibers in sheep and rodents (77,79–81). 
Additionally  KNDy cells contain NK3R (82) and KOR (83), but not Kiss1R mRNA (65). 
Administration of receptor agonists and antagonists directly into the ARC in sheep further 
support the model where NKB induces LH pulses and Dyn inhibits LH pulses. Micro-implants 
containing NKB or a KOR antagonist increased LH pulse frequency and NK3R antagonist 
containing implants decreased LH pulse frequency (70). Senktide or NKB administration 
increased LH concentrations and c-Fos in KNDy cells in sheep (84), goats (85), and rats (86). 
NKB or senktide increased spike firing in KNDy cells, but did not directly stimulate GnRH cells 
(87,88). The stimulatory effects of NKB on LH secretion in mice (89), rats (90), and primates 
(91) is dependent on functional Kiss1R, further illustrating that NKB acts via KNDy cells to 
cause kisspeptin release which stimulates LH secretion.  
Progesterone and E2 alter GnRH secretion in indirect ways because GnRH neurons do not 
contain estrogen receptor alpha (ERα) or progesterone receptor (92,93). Although some GnRH 
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neurons contain ERβ (94), there is no evidence that activation of ERβ alters gonadotropin 
secretion in sheep (95,96). Additionally, ERα but not ERβ, knock-out mice have impaired 
gonadotropin responses to E2 treatment (97). Thus it is likely that effects of steroids on GnRH 
secretion are conveyed via action on neuronal afferents to GnRH cells that contain ERα. 
Central to their role in steroid negative feedback, the expression of KNDy peptides and 
activation of KNDy cells is regulated by steroids. Cells containing mRNA for NKB are 
hypertrophied in post-menopausal woman (a natural condition of estradiol withdrawal) (98). In 
sheep, acute treatment with E2 decreased mRNA for NKB in P4 primed OVX+E2 ewes (99). 
Gonadectomy increased the number of NKB –immunoreactive (-ir) cells in the ARC in pre and 
post pubertal sheep (100). The number of cells containing kiss1 mRNA and the amount of kiss1 
mRNA per cell is increased by OVX and reduced by E2 or P4 (101). Similarly, the number of 
kisspeptin-ir cells is increased by OVX in pre-pubertal (100) and adult sheep (102) and was 
reduced with E2 treatment (103). In the caudal ARC, kiss1 mRNA is reduced by E2 or E2 plus P4 
treatment in OVX ewes, and is correlated with mean LH secretion and LH pulse amplitude (96). 
In sheep, OVX increases the percentage of kisspeptin cells that contain c-Fos in the ARC (102). 
Deletion of ERα specifically from NKB containing neurons (KNDy cells) in mice disrupts 
estrous cyclicity and causes elevated LH concentrations (104). Together these data support the 
theory that steroid negative feedback is mediated by altered expression of NKB and kisspeptin, 
and KNDy cell activation, such that steroids inhibit expression of peptides that stimulate LH 
secretion. Contrary to an abundance of evidence supporting steroid regulation of KNDy cells, 
one study reported no difference in firing frequency of ARC kisspeptin cells from OVX, diestrus 
or proestrus mice (105).   
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Thus, there is functional evidence and an anatomical framework by which three 
neuropeptides contained in a single population of neurons in the ARC generate pulsatile LH 
secretion. Moreover, these cells are regulated by ovarian steroids (E2 and P4) to facilitate 
negative feedback actions on gonadotropin secretion. However, these studies do not preclude the 
possibility that other neuropeptides or transmitters contribute to steroid negative feedback or 
regulation of pulsatile LH secretion. 
SURGE SECRETION OF LH IN SHEEP 
 
Surge secretion of LH occurs once per estrous or menstrual cycle and causes resumption 
of meiosis and ovulation. An LH surge is characterized by very high and prolonged secretion of 
LH, often over 100ng/mL and lasting hours in sheep. The LH surge is accompanied by a GnRH 
surge detectable in the hypothalamic-pituitary portal blood, that lasts several hours longer than 
the LH surge detected in the peripheral circulation (106). The GnRH and LH surge (hereafter 
referred to as LH surge) is caused by high and sustained E2 concentrations (106,107). This 
condition of E2 stimulating LH secretion is often referred to as ‘positive feedback.’ The LH surge 
is blocked by P4 (108) acting via classical progesterone receptor (109). Although E2 can 
stimulate an LH surge without prior P4 exposure, normal amplitude GnRH surge requires prior 
exposure to P4 (110). Additionally, depending on the duration and concentration of P4 exposure, 
P4 pretreatment delays the occurrence of the LH surge (111). Thus P4 has an important role in the 
preparation of neural circuits for an LH surge, though P4 itself bocks the LH surge. 
a. SITES OF ACTION OF E2 
The generation of a surge in GnRH release implies a central site of action for E2 to elicit 
the LH surge. Implants containing E2 placed into the VMN, and not other places in the 
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hypothalamus, induced LH surge secretion in ewes (112). In one study, deafferentation of rostral 
hypothalamic areas prevented, or greatly reduced, LH surge secretion in OVX ewes treated with 
estradiol benzoate and blocked ovulation in intact ewes (55). Reciprocal tract-tracing 
experiments have demonstrated that soma in the VMN project to the POA (113,114). During the 
LH surge, GnRH neurons throughout the hypothalamus (including both POA and MBH) are 
activated (as determined by c-Fos expression) (115) Together, these studies provide a framework 
in which E2 acts in the MBH and that signal is transmitted though rostral hypothalamic circuits to 
ultimately cause GnRH release. Additionally, E2 potentiates gonadotropin release during the LH 
surge by increasing the sensitivity of gonadotropes to GnRH (116). In one study, ewes with 
surgical disconnection of the hypothalamus and pituitary treated with invariant pulses of GnRH 
are able to elicit negative and positive feedback effects of E2 (117). Though estradiol benzoate 
injection did increase LH secretion in this model, the magnitude of this effect was much lower 
than a typical LH surge, illustrating involvement of hypothalamic circuits in generation of an LH 
surge.  
b. KISSPEPTIN AND NKB  
Since its discovery, discussed above, the role of kisspeptin in regulation of LH surge 
generation has been actively studied in numerous species. In sheep, kisspeptin infusion induced 
an LH surge in anestrus and hastened and synchronized the occurrence of an LH surge during the 
breeding season (64). Kisspeptin receptor blockade blunted (~50%) an estradiol benzoate 
induced LH surge in anestrus ewes (65).  
Three studies have examined c-Fos expression in kisspeptin cells during the LH surge. 
One hour after a bolus injection of E2, known to induce an LH surge in OVX ewes, there was an 
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increase in c-Fos only in ARC kisspeptin cells, similarly there was a trend for an increase in the 
percentage of kisspeptin cells that contained c-Fos during the LH surge  (118). A second report 
identified an increase in c-Fos only within POA kisspeptin cells during an LH surge in intact 
ewes synchronized with E2 and P4 (these animals had also undergone neurosurgery for other 
experiments) (119). A third report identified an increase in c-Fos in both ARC and POA 
kisspeptin cells in intact ewes killed during behavioral estrus with elevated LH concentrations 
(120). Thus, there is evidence for activation of both populations of kisspeptin neurons during the 
LH surge in sheep. 
Neurokinin B has also been implicated in the LH surge in ewes. Senktide injection into 
the 3V induces surge-like secretion of LH evident by the very high (greater than 5 fold increase) 
and sustained release of LH. Micro implants (22 gauge tubing) containing crystalline senktide 
placed into the RCh or POA, but not ARC or periventricular region caused a similar surge-like 
release of LH (69). Application of an NK3R antagonist to the RCh, but not POA, blunted 
(~50%) the amplitude of an E2 induced LH surge in OVX ewes (69). Activation of NK3R 
containing cells in the RCh induced c-Fos expression in the ARC kisspeptin cells and the 
stimulatory effects on LH secretion has been blocked by icv application of a Kiss1R antagonist 
(84). Neurons in the RCh that presumably contain NK3R project onto KNDy cells in the ARC, 
however, the phenotype of these cells is unknown (84). Together, these studies demonstrate a 
role for kisspeptin and NKB in the generation of the full LH surge. Of note, is that application of 
either the Kiss1R or NK3R antagonist blunted the LH surge by only about half. Though 
pharmacological limitations could account for this, other signaling molecules likely contribute to 
the generation of the LH surge. 
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BRIEF COMPARISONS TO THE HUMAN MENSTRAUL CYCLE 
 
 Compared to sheep (and other domestic livestock species), humans have a relatively short 
follicular phase lasting three days compared to approximately 14 in humans. The primary cause 
of this difference is likely that the CL in humans/primates, unlike sheep, secrete E2 and inhibin 
which act to potently suppress FSH secretion and therefore follicular development (17). As a 
result, follicles in humans are relatively smaller at the end of the luteal phase compared to sheep 
(121), and therefore require extended gonadotropin support to achieve growth sufficient to 
stimulate ovulation. The surge generation mechanisms also differ between sheep and humans: 
unlike sheep, complete neural deafferentation of the MBH does not prevent ovulation in 
monkeys (122).   
BRIEF COMPARISONS TO THE RODENT ESTROUS CYCLE 
 
The length of estrous cycles differ markedly in sheep (17 days) and rodents (4-5 days). 
The rodent estrous cycle consists generally of one day of proestrus, one day of estrus and 2 days 
of diestrus. Ovulation occurs on the evening of proestrus and CL form, however these structures 
do not secrete sufficient P4 to support a decidua reaction. Coitus or mechanical stimulation of the 
cervix stimulates secretion of prolactin (the luteotropin in rodents) to maintain the CL and 
stimulate P4 secretion for 12 days which allows for decidua reaction and implantation (123). 
 The relative importance of NKB signaling in rodents appears to differ from other species. 
In humans, mutations in the genes that encode NKB or its receptor cause hypogonadotropic 
hypogonadism (71). But in mice, genetic deletion of tac2 (encodes NKB) or tacr2 (encodes 
receptor for NKB) yielded modest effects only in females (124) or no reported effect on 
reproduction (125), respectively. In OVX rats, pulsatile LH secretion was inhibited by 
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administration of a cocktail of NK1R, NK2R and NK3R receptor antagonists, but not by any one 
antagonist alone. Similarly, ARC kisspeptin cell firing induced by NKB was only inhibited by a 
cocktail of all three receptor antagonists and not any single antagonist alone in mice (126). 
Therefore it is possible that in rodents the other tachykinins and tachykinin receptors can provide 
compensation to maintain gonadotropin secretion. In sheep, high doses of Neurokinin A (relative 
to NKB) or higher doses of substance P stimulate LH secretion. The relative potency of these 
molecules matches the relative affinity of these molecules for NK3R, which likely means NKB-
NK3R signaling is more important for LH secretion than the other tachykinins in sheep (68). 
There are also critical differences in the LH surge generating mechanisms in rodents 
compared to sheep. First, E2 implants placed into the POA, and not elsewhere, stimulate surge 
LH secretion (127). Several lines of evidence support the hypothesis that the LH surge is 
mediated by the rostral population of kisspeptin neurons. Estradiol increases kiss1 mRNA within 
the rostral population of kisspeptin cells in OVX rats (128) and kiss1mRNA abundance is 
highest during the evening of proestrus (129), while similar changes were not observed in the 
ARC. Additionally, c-Fos expression was increased in this kisspeptin population during the 
evening of proestrus in mice and rats (129–131). Full expression of the LH surge in OVX and 
E2-primed rats requires P4 and E2 (132). Whereas in sheep, E2 alone is sufficient the stimulate an 
LH surge of normal amplitude (133). Additionally, circadian inputs from the suprachiasmatic 
nucleus (134) are critical in generating the LH surge in rats which only occur in the afternoon 




SEASONAL BREEDING IN SHEEP 
 
Sheep, like most mammals, are seasonal breeders (humans and laboratory rodents are 
notable exceptions). Seasonal breeding is an effective strategy for synchronizing the birth of 
young with seasonal variations in resources necessary for their survival. Ewes are fertile in the 
fall, when day length is shortening and are referred to as short day breeders. Photoperiod is the 
environmental factor used to time reproduction in sheep. Melatonin is secreted from the pineal 
gland at night (136). Photoperiod (technically length of night) is encoded by the duration of 
melatonin secretion which acts to synchronize circannual rhythms of fertility and sensitivity to 
E2 negative feedback in sheep (137,138). The inhibition of gonadotropin secretion during the 
anestrus season is mediated by steroid-dependent and a more modest steroid-independent 
mechanism evident in OVX ewes. 
a. STEROID-DEPENDENT SUPPRESSION OF GONADOTROPIN SECRETION 
 
During seasonal anestrus, but not the breeding season, low concentrations of E2 inhibit 
LH pulse frequency (139). This heightened sensitivity to E2 negative feedback occurs during 
anestrus (140) due, at least in part, to activation of an inhibitory A15 dopaminergic neurons with 
cell bodies in the RCh (141–145) and project to the MBH (143). Moreover, KNDy cells receive 
direct input from dopaminergic terminals (146) and contain the relevant dopamine receptor 
(D2R) (147).  Administration of D2R stimulates LH in a kisspeptin dependent manner (147). In 
anestrus, E2 acts in the RCh (95) and the POA (148) to suppress LH via afferents to A15 




b. STEROID INDEPENDENT SUPPRESSION OF GONADOTROPIN SECRETION 
 
Evidence for steroid-independent suppression of gonadotropin secretion stems from the 
observation that OVX ewes during anestrus have a lower LH pulse frequency than OVX ewes 
during the breeding season (139).  The only signaling molecule that has been implicated in this 
phenomenon is serotonin. Serotonin receptor blockade (methysergide or cyprohetadine) 
increased LH pulse frequency in OVX ewes in anestrus but not during the breeding season 
(150,151). Serotonin depletion during anestrus also increased LH pulse frequency in OVX ewes, 
but had no effect in OVX ewes treated with E2 (151). However a 5-HT receptor antagonist 
(cyprohetadine) increased LH pulse frequency in E2 treated OVX ewes (152), but not in intact 
ewes (153), during anestrus. Thus, it is likely that the steroid-independent effects of serotonin to 
suppress LH are present in E2 treated ewes, in which LH is suppressed by a combination of E2 
and these other steroid-independent factors. Furthermore, selective (ketanserin and 
methysergide) and non-selective (cyprohetadine) 5-HT receptor antagonists all increased LH 
pulse frequency, data that are consistent with action at the 5-HT2 receptors (154).  
SOMATOSTATIN 
 
Somatostatin (SST) is a 14 or 28 amino acid peptide cleaved from preproSST protein. 
SST is produced in diverse tissues throughout the body, including many portions of the brain. 
SST immunoreactive neurons have been detected throughout the ovine hypothalamus, including 
populations in the ARC, VMN, POA and paraventricular region (155). The diverse effects of 
SST are mediated by five isoforms of the somatostatin receptor (SSTR1-5). All isoforms are G-
alpha inhibitory type G-protein coupled receptors. Activation of these receptors inhibits 
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adenylate cyclase activity and causes membrane hyperpolarization by increasing potassium 
channel conductance (156).  
The best known effects of SST are to suppress growth hormone secretion from the 
anterior pituitary, opposing the actions of growth hormone releasing hormone (157). 
Additionally, SST suppresses thyroid stimulating hormone pulse frequency and amplitude (158). 
In rats, only SST cells in the periventricular nucleus project to the median eminence (159).  
Somatostatin has been demonstrated to suppress LH secretion in humans, sheep and 
rodents. In humans, iv SST infusion (158) and subcutaneous injections of the SST receptor 2 
(SSTR2) agonist octreotide (160) suppressed LH secretion. In rodents, SST inhibited GnRH 
release from hypothalamic explants (161) and GnRH spike firing from hypothalamic slices in 
mice (162) and rats (163). Additionally, a SSTR2 agonist blunted the LH surge and prevented 
the typical increase in the percentage of GnRH cells expressing c-Fos during the LH surge (164). 
Thus there is both in vitro and in vivo data for action of SST within the hypothalamus of rodents 
to inhibit LH secretion.  
The primary site of action for SST in rodents is likely the POA, as SST has direct actions 
on GnRH cells and GnRH cells contain mRNA for SST receptors (162,163). In mice, SST fibers 
have been observed in close apposition to GnRH soma (162). However in rats, SST fibers have 
not been observed in close apposition to GnRH soma and only rarely in apposition to GnRH 
fibers, which raises the possibility of SST acting via volume transmission (163). 
In sheep, icv infusion of SST inhibits pulsatile LH secretion (165), however most work 
has focused on the LH surge. Several lines of evidence suggest that SST may be involved in 
surge secretion of LH. First, approximately 30% of the SST cells in the VMN (site of E2 positive 
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feedback discussed above) contain ERα (155,166). Second, ewes treated with E2 implants known 
to cause an LH surge had more preproSST per cell within the VMN than control treated ewes. 
However, the increase in preproSST mRNA was detected at a time when E2 inhibits LH 
secretion (before the LH surge) (165). Third, the percentage of SST cells that contained c-Fos 
within the VMN was greater in ewes with naturally occurring LH surges (167) or anestrus ewes 
treated with estradiol benzoate (155) compared to early follicular phase ewes or oil treated 
anestrus ewes, respectively. Finally, prenatally androgenized ewes, which do not display surge 
type LH secretion, had a lower percentage of SST cells that contained c-Fos following E2 
implant insertion compared to normal ewes (168).  
SST may act in the POA of sheep as SST fibers have been observed in close apposition to 
GnRH cells in the POA (168) and a preliminary report indicate that GnRH cells in the POA 
contain SSTR2 (but not the other SST receptors) as detected by immunohistochemistry (169). 
Thus, the hypothalamic site of action for SST may be direct action at the GnRH neurons within 
the hypothalamus. 
SPECIFIC AIMS 
As review above,  several studies have shown that exogenous SST inhibits LH secretion 
in sheep, rodents and humans.  However, there is no clear evidence that endogenous release of 
SST plays an important role in control of LH. Therefore, we propose 3 aims to investigate the 
role of endogenous SST in the regulation of gonadotropin secretion in sheep and to study the 
neuroanatomical substrates that may mediate the effects of SST on LH secretion. 
Specific Aim 1: To determine if endogenous SST alters pulsatile or surge secretion of LH. We 
hypothesize that endogenous SST inhibits pulsatile and surge secretion of LH in sheep. To 
determine if SST contributes to LH surge secretion, we administered a SSTR2 agonist and 
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antagonist to ewes during the LH surge. To determine if SST contributes to pulsatile LH 
secretion, we administered an SSTR2 antagonist to ovary intact ewes during anestrus and luteal 
phase of the estrous cycle. Additionally, we measured c-Fos expression in GnRH and kisspeptin 
cells in ovary-intact anestrous ewes following SSTR2 blockade. To determine if the stimulatory 
effects of SSTR2 blockade on LH secretion was dependent on steroids, we applied the antagonist 
to OVX ewes during both the breeding season and anestrus.  
Specific Aim 2: To determine whether SST could act directly on GnRH or KNDy cells, we 
analyzed SST synapses onto GnRH or KNDy cells in ewes from throughout the estrous cycle 
and anestrus. 
Specific Aim 3: To determine whether SST cells in the VMN are activated during the LH surge. 
First we confirmed that c-Fos is increased in SST cells in the VMN during the LH surge. 
Because neither a SSTR2 agonist nor antagonist altered LH surge secretion in Chapter 2 (Aim 1), 
we hypothesized that SST cells in the VMN produce additional signaling molecules that may 
contribute to the LH surge. To test this possibility, we examined SST and nNOS colocalization 
in the VMN. We analyzed c-Fos expression during the surge in the subset of neurons that contain 
both SST and nNOS. We also determined whether c-Fos expression in SST cells was increased 
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Two modes of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) 
secretion are necessary for female fertility: surge and episodic secretion, however the neural 
systems that regulate these GnRH secretion patterns are still under investigation. The 
neuropeptide somatostatin (SST) inhibits episodic luteinizing hormone (LH) secretion in humans 
and sheep, and several lines of evidence suggest SST may regulate secretion during the LH 
surge. In this study, we examined whether SST alters the LH surge in ewes by administering a 
SST receptor 2 (SSTR2) agonist (octreotide) or antagonist (CYN154806; CYN) into the third 
ventricle during an estrogen-induced LH surge, and whether endogenous SST alters episodic LH 
secretion. Neither octreotide nor CYN altered the amplitude or timing of the LH surge. 
Administration of CYN to intact ewes during the breeding season or anestrus increased LH 
secretion and increased c-Fos in a subset GnRH and kisspeptin cells during anestrus. To 
determine if these stimulatory effects are steroid-dependent or -independent, we administered 
CYN to ovariectomized ewes. This SSTR2 antagonist increased LH pulse frequency in 
ovariectomized ewes during anestrus, but not during the breeding season.  This is the first 
evidence in any species that endogenous SST contributes to the control of LH secretion. The 
results demonstrate that SST, acting through SSTR2, inhibits episodic LH secretion, likely acting 
in the mediobasal hypothalamus, but action at this receptor does not alter surge secretion. 
Additionally, these data provide evidence that SST contributes to the steroid-independent 





Neither a SSTR2 agonist nor antagonist altered the LH surge but the latter stimulated episodic 
LH secretion by increasing mean LH in intact ewes and increasing LH pulse frequency in 
ovariectomized anestrous, but not breeding season ewes. 
INTRODUCTION 
 
Ovarian function, and therefore fertility in females, is dependent on cyclical changes in 
two modes of gonadotropin secretion. Surge secretion of LH occurs once per estrous or 
menstrual cycle at the end of the follicular phase in response to positive feedback effects of E2 
and induces ovulation and luteinization. Pulsatile secretion of luteinizing hormone (LH) is 
necessary for folliculogenesis and steroidogenesis, and is regulated by negative feedback effects 
of estradiol (E2) and progesterone, with progesterone inhibiting LH pulse frequency and E2 
inhibiting pulse amplitude (1). These actions result in changes in LH pulse patterns during the 
normal ovarian cycle that are important for the control of ovulation because the increasing 
episodes of LH secretion during the follicular phase drive the pre-ovulatory rise in circulating E2. 
Increased LH pulse frequency also underlies the transition from infertility to reproductive 
competence at the onset of puberty and the transition into the breeding season.  In several 
species, these changes are controlled by both steroid-dependent (changes in response to the 
negative feedback actions of E2 or testosterone) and steroid-independent (evident in 
gonadectomized animals) inhibition of LH pulse frequency, but the importance of each varies 
with species (2). In sheep, the steroid-dependent suppression, which reflects an increased ability 
of E2 to inhibit gonadotropin-releasing hormone (GnRH) and LH pulse frequency prior to 
puberty and during the non-breeding (anestrous), is more dramatic than the modest decrease in 
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GnRH and LH pulse frequency seen in ovariectomized (OVX) animals (3). In contrast, steroid-
independent  suppression of LH is evident and critical for prepubertal suppression of LH in the 
agonadal monkey (4,5) and children (6,7). 
 
The neurons that produce GnRH do not contain estrogen receptor alpha (ERα) or 
progesterone receptor (8–10), implicating a role for neuronal afferents to GnRH cells that convey 
the negative and positive feedback signals. The neuropeptide somatostatin (SST) is produced 
throughout the CNS, including the hypothalamus and preoptic area (POA), and may contribute to 
the regulation of both episodic and surge secretion of LH. SST exerts its effects via five different 
Gi/o protein-coupled receptors (SSTR1-5). Activation of these receptors inhibits adenylate 
cyclase activity and opens potassium channels, resulting in membrane hyperpolarization and 
therefore reduced responsiveness to stimulatory input (11). Consistent with a generally inhibitory 
effect, SST inhibited GnRH release from rat hypothalamic explants (12) and  spike firing in 
GnRH cells in mice (13) and rats (14). Furthermore, these actions are likely mediated, primarily 
through SSTR2 because the SSTR2 agonist, seglitide, produced similar inhibition of spike firing 
and membrane hyperpolarization as SST in mice (13). 
SST neurons in the ventromedial nucleus (VMN) of the ovine hypothalamus contain ERα 
(15,16) and several lines of evidence suggest that they may be involved in the positive feedback 
actions of E2 in ewes (female sheep).  First, the VMN is considered the site of E2 positive 
feedback in ewes because E2 microimplants placed into this area, but not elsewhere, induced an 
LH and GnRH surge (17). Second, ewes treated with E2 implants known to induce an LH surge 
24 hrs later had more preproSST mRNA per cell (in the VMN) than ewes that did not receive E2 
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implants (18). It should be noted that the increase in preproSST mRNA was observed shortly (4 
hrs) after E2 implants were inserted, a time when E2 inhibits LH secretion. Third, c-Fos 
expression was higher in SST neurons within the VMN of ewes at the time of naturally occurring 
LH surges (19) and in anestrous ewes treated with estradiol benzoate than in controls (16). 
Finally, intracerebroventricular (icv) administration of the SSTR2 agonist, octreotide, blunted the 
LH surge and prevented the typical increase in c-Fos within GnRH cells, in rats (20). More direct 
evidence exists for a possible role for SST in regulation of pulsatile LH secretion. Infusion of  
SST into the third ventricle using an early follicular phase model in ewes inhibited mean LH 
concentrations and the  number of LH pulses (18). Similarly, intravenous (iv) SST infusion into 
healthy humans (women in the follicular phase of menstrual cycle and men) suppressed mean 
LH concentrations (21) and octreotide suppressed pulse amplitude and mean LH concentrations 
in women with polycystic ovarian syndrome (22). 
In this study, we tested the hypothesis that SST, acting via SSTR2, acts in the 
hypothalamus to suppress both the LH surge and episodic LH secretion in ewes. We targeted 
SSTR2 based on evidence that this receptor mediates the actions of SST in rodents (13,20) and 
that GnRH cells in the preoptic area of sheep contain SSTR2, but not the other SST receptor 
subtypes, as determined by immunohistochemistry (23). To determine the role (if any) of SST on 
the generation of the LH surge, we administered either a SSTR2 agonist or antagonist to ewes 
during an E2-induced LH surge. To determine if endogenous SST alters episodic LH secretion, 
we administered a SSTR2 antagonist to ovary-intact breeding season ewes during the luteal 
phase (when progesterone is the dominant suppressor of LH), to ovary-intact ewes during 
anestrus (when E2 is the dominant suppressor of LH) and to OVX ewes during both the breeding 
and anestrous season.  Previous work in sheep had provided no evidence on the neural sites of 
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action of SST.  Therefore, we administered the SSTR2 agonist and antagonist into the third 
ventricle because this approach has the advantage of testing a functional role for SST signaling 
without a priori information of sites of action. 
MATERIALS & METHODS 
 
Animals 
Multiparous mature ewes (>3years old) of mixed breeding were maintained in a light and 
temperature controlled research building. Lighting conditions were adjusted every other week to 
mimic local natural lighting conditions. Ewes were fed a maintenance ration of cubed alfalfa hay 
and had free access to water and mineral blocks. Breeding season experiments were done in 
October and November and anestrous studies were done in May and June. All procedures were 
approved by the West Virginia University Animal Care and Use Committee and were performed 
in accordance with the NIH guidelines for the care and use of research animals. 
General Methods 
Surgical procedures: All surgeries were performed using aseptic techniques with 
anesthesia maintained with 2-5% isofluorane in oxygen. Wool was removed from the surgical 
site and skin was scrubbed with betadine solution. For OVX, the reproductive tract was 
externalized by mid-ventral laparotomy, the ovarian blood supply was ligated with suture and 
ovaries were removed. The remaining reproductive tract was rinsed with sterile saline to 
minimize adhesions and returned to the abdominal cavity. Peritoneum, subcutaneous layers and 
skin were closed with suture. For neurosurgery, an 18 gauge needle was prepared and placed in 
the caudal, basal portion of the third ventricle using a stereotaxic procedure as previously 
described (24). The cannula was cemented in place with dental acrylic, the needle hub was 
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plugged and covered with a plastic cap. Animals were treated pre- and post-operatively with 
analgesics (carprofen for both surgery types and gabapentin for neurosurgeries) and antibiotics 
(ampicillin for both surgery types and gentamycin for neurosurgeries). All veterinary drugs were 
acquired from Patterson veterinary (Bessemer, AL), except gabapentin which was compounded 
locally (McCracken Pharmacy, Waynesburg, PA). Animals were allowed to recover from 
surgery for at least 1 week before any experiments were performed. 
Drug preparation and blood sampling procedures: Drugs for icv injection were prepared 
the night before injection and sterilized with UV irradiation. Animals were treated 
prophylactically with gentamicin before and after the blood sampling period. For studies of 
surge-type LH secretion, blood samples were collected at 2-4 hr intervals during the expected 
time of the LH surge. For studies of episodic LH secretion (Exp. 2-4), blood samples were 
collected at 12 min intervals from 2 hrs before until 4 hrs after drug or vehicle injection. For all 
experiments, jugular blood samples (3-4 mL) were collected via venipuncture and placed in 
heparinized tubes. Plasma was harvested and stored at -20 C until assayed for LH with RIA.   
Experiment 1: Does SST act in the hypothalamus to regulate surge-type LH secretion? 
In order to identify an effective dose of the selective SSTR2 agonist, octreotide, that 
would alter LH secretion, in a preliminary experiment, we administered 20 nmol of octreotide 
(Tocris Bioscience, Ellisville, MO) in 100 uL of artificial cerebrospinal fluid (aCSF) (25) to 
OVX ewes. LH concentrations were measured in blood samples collected at 12 min intervals 
from 3 hrs before to 7 hrs after drug administration. Octreotide was selected for these 
experiments because it has been demonstrated to alter LH secretion in rats (20) and humans (22).  
A single 20 nmol icv injection of octreotide suppressed mean LH (pre: 8.1 ± 1.5 ng/mL; post: 2.8 
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± 0.6 ng/mL) and pulse amplitude (pre: 8.7 ± 3.7 ng/mL; post: 2.3 ± 0.8 ng/mL) for the entire 
post injection sampling period (Fig. 1). However, inter-pulse interval (IPI) was not obviously 
altered (pre: 47.3 ± 6.4 min; post: 56.3 ± 6.7 min).  
We used a well-established artificial follicular phase model in OVX ewes to test the 
effects of a SSTR2 agonist and antagonist on the E2-induced LH surge (26).  Briefly, at the time 
of OVX and insertion of third ventricle cannula, a small (1 cm long) Silastic implant (inner 
diameter 0.34Cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI) containing E2 was 
inserted subcutaneously (sc) and remained in place for the entire experiment. Two progesterone 
containing CIDRs (Zoetis, Parsippany, NJ) were also inserted vaginally at this time. Eight days 
later the CIDRs were removed and the next day 4 large (3 cm long) E2 implants were inserted sc 
and removed 3 days later.  Blood samples were collected at 2 hr intervals for 36 hrs starting at 
the time of large E2 implant insertion, and then at 4 hr intervals for an additional 12 hrs. This 
treatment protocol reliably induces an LH surge 20-24 hrs after insertion of the large E2 implants. 
To test the effect of a SSTR2 agonist, six ewes were randomly assigned to receive icv injections 
of either the SSTR2 agonist, octreotide (20 nmol in 100uL) or aCSF every 8 hr for the first 24 
hrs of blood sampling starting at the time of E2 implant insertion. This dosing regimen was 
chosen based on results from the preliminary experiment. Three days after removal of large E2 
implants, this progesterone pretreatment, surge induction and experimental protocol (icv 
injections and blood sampling) was repeated with each ewe receiving the alternate treatment in a 
cross-over design. 
To test the effects of the SSTR2 antagonist, seven adult ewes were OVX and a permanent 
cannula placed into the third ventricle at least 1 week before any experimental procedure. An LH 
surge was induced as described above. Ewes were randomly assigned to receive icv injections of 
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either the selective SSTR2 antagonist, CYN154806 (CYN) (27) (60 nmol in 100 uL; Tocris 
Bioscience, Ellisville, MO; n=4), or equal volume of saline (n=3) at 6 hr intervals for 24 hrs 
starting at the insertion of large E2 implant treatment. This dose of antagonist altered pulsatile 
LH secretion in Exps. 2-5 below. 
Experiment 2: Does endogenous SST act in the hypothalamus to regulate tonic LH 
secretion in intact anestrus ewes? 
Eight ovary-intact anestrous ewes received a permanent cannula into the third ventricle in 
mid-April (non-breeding season). Ewes were randomly assigned to receive a single icv injection 
of CYN (60 nmol in 100uL sterile saline), or vehicle with 6 hrs of frequent blood collection. The 
protocol was repeated 4 days later in which each animal received the alternate treatment in a 
cross-over design. 
Experiment 3: Does endogenous SST act in the hypothalamus to regulate tonic LH 
secretion in luteal phase ewes? 
Eight ovary-intact ewes received a permanent cannula into the third ventricle in mid-
October (breeding season). Estrous cycles were synchronized with 2 intramuscular injections of 
PGF2α (20mg, Lutalyse, Zoetis, Parsippany, NJ ) given 7 days apart (28). Eight days after the 
second injection, ewes were randomly assigned to receive a single icv injection of CYN (60nmol 
in 100uL sterile saline), or 100 L of vehicle and frequent blood samples were collected for 2 hrs 
before and 4 hrs after injections as described above. The protocol was repeated 2 days later in 




Experiment 4: Effects of SSTR2 blockade on GnRH and kisspeptin cell activation 
To determine whether SST may act via GnRH or kisspeptin cells, we administered CYN 
or saline via icv injection and examined c-Fos expression in GnRH or kisspeptin cells using 
immunohistochemistry. Six days after the final sampling period in experiment 2, the same intact 
ewes were randomly assigned to receive either saline (n=4) or CYN (n=4). Animals were 
euthanized and hypothalamic tissue was collected 2 hrs after injection. 
Ewes were treated with heparin (20,000 U) 10 min before and at the time of euthanasia, 
which was performed with an overdose (8-16 mL, iv) of sodium pentobarbital (Euthasol, 
Patterson Veterinary, Bessemer, AL). The head was rapidly removed and perfused with 6L of 
4% paraformaldehyde in 0.1M phosphate buffer (PB) with 0.1% NaNO3. A block of tissue 
including the hypothalamus and pre-optic area (POA) was removed and stored overnight in the 
same paraformaldehyde solution at 4°C. Tissue was then transferred to 20% sucrose in PB and 
maintained at 4°C. After sucrose infiltration, tissue was frozen and 45μm-thick-coronal sections 
were cut with a microtome with a freezing stage and collected in 10 series (450μm apart) and 
stored at -20°C in cryoprotectant solution (29). 
For detection of GnRH and c-Fos, dual label immunohistochemistry was performed on 
one complete series of hemi-sections throughout the hypothalamus. All steps were performed at 
room temperature with mild agitation, unless noted differently. Tissue was rinsed in 0.1M PB 8 
times (15 min each) and stored overnight in PB at 4°C. Tissue was rinsed 12 additional times in 
0.1M phosphate buffered saline (PBS; 15 min each). Endogenous peroxidase activity was 
quenched by incubation in 1% H2O2 in PBS, after which tissue was rinsed 4 times for 5 mins 
each in PBS (typical rinsing step). Tissue was incubated in 4% normal goat serum (NGS; 
Jackson Immunoresearch, West Groove , PA)  in PBS containing 0.04% triton X-100 (PBST) for 
46 
 
1 hr and then incubated in rabbit anti-c-Fos serum (dilution: 1:2000 with 4% NGS in PBST; SC-
52, RRID: AB_2106783, Santa Cruz Biotechnology, Dallas, TX) for 17 hrs. Tissue was rinsed, 
and incubated sequentially in biotinylated goat anti-rabbit immunoglobulin (IgG; dilution: 1:500 
in PBST with 4% NGS; BA-1000; Jackson Immunoreseach) for 1 hr, ABC-elite (dilution 1:500 
in PBS; Vector Lab Burlingame, CA) for 1hr and nickel enhanced 3’3’Diaminobenzidene 
solution (10mg per 50mL PB with 2mL of 2% NiSO4 and 20μL of 30% H2O2 to produce a black 
reaction product, Sigma-Aldrich, Saint Louis, MO) for 10 min with intervening rinse steps. 
Tissue was then rinsed in PB and placed into 1% H2O2 in PBS, rinsed and incubated in blocking 
solution containing 4% NGS in PBST for 1 hr, and was incubated in rabbit anti-GnRH serum 
(dilution: 1:2000 in PBST with 4% NGS, 20075, RRID:AB_572248, Immunostar, Hudson, WI) 
for 1 hr. Tissue was rinsed in PBS and incubated sequentially in biotinylated goat anti-rabbit IgG 
(dilution: 1:500 in PBST with 4% NGS), ABC-elite (dilution: 1:500 in PBS), and 3,3’-
diaminobenzidine (10mg per 50mL PB with 20μL of 30% H2O2 to produce a brown reaction 
product) for 10 min. Tissue was rinsed in PB and mounted onto superfrost slides (Fisher 
Scientific, Pittsburgh, PA), once dried, cover glass was applied with Eukitt (Fisher Scientific, 
Pittsburgh, PA) mounting media. 
The total number of GnRH cells and the percentage of GnRH cells that contained c-Fos 
was determined in the diagonal Band of Broca, POA, anterior hypothalamic area, and the 
mediobasal hypothalamus (MBH), (30) with a bright field microscope (Axiovert 400CFL, Zeiss) 
with a 20x objective. Values were averaged per animal. All cell counts were made by a single 
observer blinded to treatment groups. 
Detection of c-Fos within kisspeptin cells was performed in one series of hemi-sections 
from throughout the arcuate nucleus (ARC), which contains the population of kisspeptin-
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neurokinin B-dynrophin (KNDy) neurons (31,32), and in 2-4 hemi sections from the POA as 
described above except that 10%  H2O2 and 20% NGS were used in blocking solutions and a 
kisspeptin antibody (dilution: 1: 10K in PBST with 4% NGS; AB9754, RRID:AB_2296529, 
Millipore, Billerica, MA) was used following detection of c-Fos. The total number of  kisspeptin 
cells and the number of kisspeptin cells that contain c-Fos were determined in 2-4 sections in the 
rostral, middle and caudal portions of the ARC (32) and POA. The mean number of kisspeptin 
cells per hemi section, and percent of kisspeptin cells that contained c-Fos were averaged per 
animal.  All cell counts were made by a single observer blinded to treatment groups using a 
bright-field microscope (VS120 Olympus, Tokyo, Japan) with a 20x objective. Antibodies used 
to detect c-Fos (32,33), GnRH (34)  and kisspeptin (35) have been validated and used 
extensively in sheep, additional details about these antibodies are presented in Table 1. 
Experiment 5: Does endogenous SST suppress LH in a steroid-independent manner? 
To determine whether the stimulatory effects of SSTR2 blockade observed in experiment  
3 were dependent or independent of gonadal steroid inhibition of LH secretion, we administered 
CYN to six OVX ewes during anestrus (June). Seven to ten days after OVX, animals were 
randomly assigned to receive a single icv injection of CYN (60 nmol in 100uL sterile saline) or 
vehicle, with frequent blood samples collected for 6 hrs. They then received the alternate 
treatment 5 days later in a crossover design.  
In light of the results of the first part of this study, we next determined if endogenous SST 
mediates the steroid-independent suppression of LH caused by inhibitory photoperiod by giving 
CYN to eight OVX ewes during the breeding season (mid-November). Animals were randomly 
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assigned to receive treatments (CYN or saline as described above) 6-9 days after OVX and 
received the alternate treatment 2 days later. 
Data Analysis 
Radioimmunoassay 
LH concentrations were measured in duplicate as described previously (36) using a 
double-liquid phase RIA with reagents provided by the National Hormone and Peptide Program. 
The sensitivity of the assay averaged 0.077 ng/tube (NIH S24), the intra- and inter-assay 
coefficients of variation were 5.8% and 8.3%, respectively. Progesterone concentrations were 
determined using a RIA kit (MP Bioscience, Santa Anna, CA) according to the manufacturer’s 
directions. Progesterone was measured in duplicate in a single assay with a sensitivity of 0.012 
ng/tube and an intra-assay coefficient of variation of 10.1%.  
 
Statistical Analysis 
For experiment 1, the time of maximal LH secretion and the amplitude of the LH surge 
(maximal concentration minus LH concentration of the first sample collected at time of insertion 
of  large E2 implants) were compared between treatment groups with t-tests (paired t-tests for 
experiments conducted as cross-over designs). In studies of episodic LH secretion, pulses were 
identified with established criteria (1); briefly, a pulse had to be 2 assay standard deviations 
greater than the preceding nadir, the pulse had to occur within 2 samples of the preceding nadir 
and the amplitude had to be greater than the assay sensitivity.  The total number of GnRH or 
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kisspeptin cells and the percentage of each that contained c-Fos within each area were compared 
between treatment groups with independent t-tests. 
For experiments examining episodic LH secretion, mean LH concentration and LH pulse 
amplitude (maximal pulse value minus preceding nadir) were determined during the 2 hrs pre- 
and 4 hrs post-injection sampling period and analyzed by two-way ANOVA with repeated 
measures (time and treatment); Tukey’s multiple comparisons test was used to determine 
differences between individual points where appropriate. LH inter-pulse interval (IPI) was 
determined during the 4 hr post-injection period and was compared between treatment groups 
with paired t-test. Post-injection pulse latency (time from injection to the first pulse) and the 
amplitude of the first pulse after injection was compared between treatment groups with a paired 
t-test. P < 0.05 was considered statistically significant. 
RESULTS 
 
Effects of SSTR2 agonist and antagonist on surge type LH secretion 
Estradiol treatment induced an LH surge in all animals. Administration of the SSTR2 
agonist, octreotide, did not alter either the amplitude of the LH surge or the timing of the LH 
peak compared to aCSF treated animals (Fig 2, upper panels). Similarly, administration of the 
SSTR2 antagonist, CYN did not alter the amplitude or the peak time of the LH surge compared 
to saline treated animals (Fig 2, lower panels). 
Effects of SSTR2 antagonist in anestrous ewes 
One ewe apparently had an LH surge during one sampling period (evident by very high 
and sustained LH concentration patterns) and was thus removed from analysis. A single injection 
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of CYN into anestrous ewes induced pulse-like LH secretion in all 7 ewes within 36 min. Four of 
these ewes also had an LH pulse within 36 min after injection of saline (Fig 3). For mean LH, 
two-way ANOVA revealed a significant time by treatment interaction such that CYN 
significantly increased mean LH concentrations (Pre: 1.4 ± 0.2 ng/mL; Post: 4.3 ± 0.7 ng/mL), 
whereas saline injections did not alter mean LH (Pre: 1.3 ± 0.1 ng/mL; Post: 2.4 ± 0.4 ng/mL). 
Pulse amplitude during the post injection period tended (P=0.089) to be greater in animals that 
received CYN (4.7 ± 0.9 ng/mL) than saline (2.7 ± 0.5). Neither IPI  (Fig 3) nor timing of the 
first pulse (data not shown) was different between the two treatments. 
Effects of SSTR2 antagonist in luteal phase ewes 
 The synchronization protocol using prostaglandin resulted in luteal phase concentrations 
of progesterone (>1 ng/mL) in 7 of 8 ewes on both sampling days; one ewe with low 
progesterone concentrations was excluded from analysis. Two-way ANOVA for mean LH 
revealed a significant time by treatment interaction such that a single icv injection of CYN into 
luteal phase ewes produced a modest, but significant increase in mean LH concentrations (Fig 3, 
Pre: 1.0 ± 0.2 ng/mL; Post: 1.4 ± 0.2 ng/mL), whereas saline injections did not alter mean LH 
concentrations (Pre: 1.0 ± 0.3 ng/mL; Post: 1.1 ± 0.3 ng/mL). The first pulse after CYN injection 
occurred sooner (24 ± 4.5 min) than the first pulse after saline injection (58 ± 10.3 min). Neither 
pulse IPI (Fig 3) nor amplitude (data not shown) was significantly altered by treatment with this 
antagonist. 
Effects of SSTR2 antagonist on GnRH and kisspeptin cell activation 
Ewes that received CYN had a significantly greater percentage of GnRH cells that 
contained c-Fos within the MBH compared to ewes that received saline (Fig 4). There were no 
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significant differences in the percentage of GnRH cells that contained c-Fos in the diagonal band 
of Broca, POA or anterior hypothalamic area between treatment groups. CYN had no significant 
effect on the total number of GnRH cells in any of these areas (Table 2).  
Ewes that received CYN had a significantly greater, though modest, percentage of 
kisspeptin cells that contained c-Fos within the caudal aspect of the ARC compared to ewes that 
received saline (Fig 4). CYN treatment did not alter the percentage of kisspeptin cells that 
contained c-Fos in other portions of the ARC or POA. There was also no difference in the total 
number of kisspeptin cells between treatment groups in any area. Although there appeared to be 
a large numerical difference between treatment groups in the percentage of GnRH and kisspeptin 
cells that contained c-Fos in the diagonal band of Broca and  the POA, respectively, these 
differences were not statistically significant. This might be due to the relatively low number of 
animals (n=4/group), but more likely reflects the variability inherent in estimating percentages 
because there is a small number of total cells in these areas (Table 2). 
Effects of SSTR2 antagonist in OVX ewes 
Following CYN injection, OVX ewes during anestrus had a significantly shorter IPI (52.3 
± 6.9 min) than following saline injection (83.7 ± 9.6 min; Fig 5). Similarly, the first pulse after 
CYN injection tended to occur sooner (P=0.06; 32.0 ± 6.7 min) than following saline injection 
(64.0 ± 14 min).  In contrast, during the breeding season, the IPI following CYN injection did 
not differ from that following saline injection, nor did the timing of the first pulse. Of note, CYN 
administration in anestrus reduced the IPI to a duration essentially the same as that seen in OVX 
during the breeding season. CYN treatment did not alter pulse amplitude (data not shown) or 
mean LH concentrations within either season, but mean LH levels were higher during the non-
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breeding season than in the breeding season (Fig 5) because there was an increase in LH pulse 
amplitude during anestrus (anestrus: 11.0 ± 2.1 ng/mL vs breeding season 6.7 ± 0.8 ng/mL), 
which has been seen in previous studies (37,38). 
Analysis of guide cannula placement 
Cannulae placed into the third ventricle were aimed so that the tip was 2-3 mm directly 
above the infundibular recess (24), but there was some variation in this position. To determine if 
this variation affected the response to the SSTR2 antagonist, the distance from infundibular 
recess to the tip of the cannula was measured on radiographs captured during neurosurgery and 
compared to LH responses for each experiment.  As illustrated in Fig 6, for experiment 2 (intact, 
anestrous ewes), there was a negative relationship (R
2
=0.84) between the distance of the cannula 
tip to the infundibular recess and the change in mean LH concentration (mean LH concentration 
after CYN injection minus mean LH concentration pre-injection). Animals with the cannula tip 
placed further rostral and dorsal had the smallest LH response. No significant relationships 
between cannula placement and LH response following CYN or octreotide injection were 
observed in any other experiment, though there was less variability in guide cannula placement 
and response to CYN in the other experiments. 
DISCUSSION 
This is the first report to demonstrate a role for endogenous SST in regulation of GnRH 
secretion in any species. Previous work in several species has shown that SST or SST receptor 
agonists can alter GnRH cell activity or LH secretion, but the present study is the first to employ 
a SST receptor antagonist to determine whether endogenous SST suppresses LH secretion. Using 
this approach, we demonstrate that the SSTR2 antagonist, CYN, stimulates pulsatile LH 
secretion and c-Fos expression in MBH GnRH neurons, but not surge secretion. 
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Although several lines of correlative evidence in sheep, and pharmacological data in 
rodents, support a role for SST in surge type LH secretion, neither a SSTR2 agonist nor 
antagonist altered surge secretion in our experiments. Several methodological or theoretical 
considerations could account for the lack of effect of these drugs.  First, as with all 
pharmacological studies, it is possible that an effective concentration of the drug was not 
achieved in the necessary locations to elicit an effect on LH surge secretion, but these drugs did 
effect episodic LH secretion. Second, SST could be acting through one of the other somatostatin 
receptors, although as in the Introduction, SSTR2 is the most likely receptor to be involved in 
control of GnRH secretion. Third, it is well-established that several redundant systems contribute 
to the generation of the LH surge (39)  so that compensatory pathways could mask any effects 
caused by altered somatostatin signaling. Fourth, based largely on data from  humans (21,40,41) 
it is possible that SST acts at the pituitary to suppress the response of the gonadotrope to GnRH. 
Despite these caveats, the simplest explanation for the lack of effect of SSTR2 agonist and 
antagonist is that SST does not play an essential role in generation of the LH surge in sheep. 
Two groups have reported an increase in c-Fos, a marker for neuronal activation, in SST 
cells within the VMN around the time of the LH surge in sheep (16,19). One possible 
explanation for the discrepancy between these observations and our pharmacological data is that 
the cells that contain SST in the VMN are activated during the time of the surge but contain 
another signaling molecule or molecules that is/are important for surge secretion in sheep. 
Alternatively, it is possible that SST cells in the VMN are involved with inducing estrous 
behavior, since E2 implants placed into the VMN, but not other areas, induce sexual receptivity 
in ewes (42). However, one report that c-Fos increased within SST cells in the VMN in animals 
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during the LH surge but not during the portion of estrous behavior that preceded the surge (19) 
argues against this possibility.  
Perhaps the most dramatic effects of the SSTR2 antagonist on episodic LH secretion 
occurred in OVX animals, in which CYN administered to OVX ewes decreased IPI during 
anestrus but not during the breeding season. Interestingly, SSTR2 blockade during anestrus 
reduced LH IPI to levels similar to those observed for OVX ewes during the breeding season. 
Thus, we propose that SST acts during anestrus to mediate the steroid-independent actions of 
photoperiod. The only other signaling molecule that has been implicated in steroid independent 
suppression of LH during anestrus is serotonin. Similar to our current findings, serotonin 
receptor blockade increased LH pulse frequency in OVX ewes in anestrus but not during the 
breeding season (43–45). Serotonin depletion during anestrus also increased LH pulse frequency 
in OVX ewes, but had no effect in OVX ewes treated with E2 (44).  
Because both SST and serotonin have been implicated in the steroid-independent actions 
of photoperiod, these two systems may interact. The ovine hypothalamus has abundant 
serotonergic fiber innervation (46), and mRNA for the relevant receptor, 5-HT2 (47) is 
concentrated in the ventral portion of the mediobasal hypothalamus (MBH), including the VMN 
(48). It is therefore possible that serotonin inhibits LH secretion via SST neurons that are located 
in the VMN. This possibility would also be consistent with the theory that serotonin suppresses 
LH via an inhibitory interneuron since 5-HT2 receptor activation releases diacylglycerol and 
inositol triphosphate, resulting in increased protein kinase C activity and Ca
++
 influx, which are 
generally considered excitatory signaling events (49). 
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In contrast to the seasonal difference in response to CYN seen in OVX ewes, 
administration of this antagonist to ovary-intact animals increased mean LH concentrations in 
both seasons, although the effect size was larger in anestrous ewes. Although LH pulse patterns 
are similar in ovary-intact luteal phase and anestrous ewes, these patterns reflect different 
negative feedback actions of ovarian steroids. During anestrus, the heightened sensitivity to E2 
negative feedback (50) produced by the inhibitory photoperiod is due, at least in part, to 
activation of inhibitory A15 dopaminergic neurons (51–53). which suppresses kisspeptin release 
from KNDy neurons in the ARC (31,32,54). During the breeding season E2 and progesterone act 
together to suppress GnRH and LH pulse frequency and appear to act directly on KNDy neurons 
(36,39,55), which contain receptors for both E2 and progesterone (56,57).  Thus, the greater 
response in ovary-intact anestrous ewes could reflect the different inhibitory systems active at 
this time of year.  Alternatively, this greater response might be due to the combination of steroid-
independent and a more modest steroid-dependent suppression of LH by SST during anestrus 
since serotonergic  inhibition of pulse frequency is sometimes evident in the presence of E2 (45).  
Because CYN was administered into the third ventricle the pharmacological data provide 
no indication of possible sites of action.  However, the robust increase in the percentage of 
GnRH-ir cells that contained c-Fos only within the MBH, supports the possibility of an action in 
this region. Alternatively, this could reflect an indirect action of CYN, because an increase in 
episodic LH secretion by an endogenous opioid receptor antagonist or a pheromonal stimulus 
also selectively increased c-Fos in MBH GnRH neurons (58). Two other observations point to an 
action of CYN in the MBH.  First, the negative correlation between the LH response and 
distance of the cannula site from the infundibular recess within the third ventricle is more 
consistent with an action in the MBH than in the POA. Second, there was a modest increase in 
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the percentage of  kisspeptin-ir cells in the caudal aspect of the ARC that contain c-Fos following 
SSTR2 blockade. The possibility that SST acts on neural afferents to GnRH cells such as the 
KNDy neurons of the ARC (35,59), which have been implicated in the generation of GnRH 
pulses (60–64), had not been previously evaluated in any species. Thus, the stimulatory effects of 
SST2R blockade could be mediated by actions directly on a subset of GnRH neurons in the 
MBH that have been implicated in pulsatile LH secretion (58), or on KNDy neurons, or a 
combination of these substrates (Fig 7).  
In summary, these experiments demonstrate that endogenous SST, acting at least partly 
through SSTR2, inhibits episodic LH secretion, but does not alter LH surge secretion.  
Furthermore, blockade of SSTR2 in ovary-intact ewes increased mean LH in both the breeding 
season and anestrus, whereas in OVX ewes, SSTR2 blockade increased LH IPI only in anestrus. 
The use of a SSTR2 antagonist allowed us to test, for the first time in any species, the role of 
endogenous SST in the regulation of LH secretion. Together, these studies provide evidence that 
SST contributes to steroid-independent suppression of LH during anestrus, and may also have a 
minor role in the inhibitory actions of ovarian steroids on LH secretion. 
 
Acknowledgments 
We thank Miroslav Valent, Gail Sager and John Connors for technical assistance with 
radioimmunoassay and animal surgeries, and Drs. Margaret Minch and Jennifer Fridley for 
veterinary care. We also thank Dr. Al Parlow and the National Hormone and Peptide program for 
reagents used to measure LH. This work was supported by NIH Grants R01-HD039916, and 
57 
 
R01-HD082135 and NIH Grant P20GM103434 to the West Virginia IDeA Network for 
Biomedical Research Excellence.  
Imaging experiments and image analysis were performed in the West Virginia University         
Microscope Imaging Facility, which has been supported by the WVU Cancer Institute and NIH 





1.  Goodman RL, Karsch FJ. Pulsatile Secretion of Luteinizing Hormone: Differential 
Suppression by Ovarian Steroids. Endocrinology 1980; 107: 1286–1290 
2.  Goodman R. Neuroendocrine Control of Gonadotropin Secretion: Comparative Aspects. 
In: T PM, Zeleznik A, eds. Physiology of Reproduction. Academic Press, 2015; 1537–
1574 
3.  Goodman R, Bittman E, Foster D, Karsch F. Alterations in the Control of Luteinizing 
Hormone Pulse Frequency Underlie the Seasonal Variation in Estradiol Negative 
Feedback in the Ewe. Biology of Reproduction 1982; 27: 580–589 
4.  Pohl CR, DeRidder CM, Plant TM. Gonadal and nongonadal mechanisms contribute to 
the prepubertal hiatus in gonadotropin secretion in the female rhesus monkey (Macaca 
mulatta). Journal of Clinical Endocrinology and Metabolism 1995; 80: 2094–2101 
5.  Plant TM. A study of the role of the postnatal testes in determining the ontogeny of 
gonadotropin secretion in the male rhesus monkey (Macaca mulatta). Endocrinlogy 1985; 
116: 1341–1350 
6.  Winter JSD, Faiman C. Serum gonadotropin concentrations in agonadal children and 
adults. Journal of Clinical Endocrinology and Metabolism 1972; 35: 561–564 
7.  Ropelato M, Escobar M, Gottlieb S, C B. Gonadotropin secretion in prepubertal normal 
and agonadal children evaluated by ultrasensitive time-resolved immunofluorometric 
assays. Hormone Research 1997; 48: 164–172 
8.  Skinner DC, Caraty A, Allingham R. Unmasking the progesterone receptor in the preoptic 
area and hypothalamus of the ewe: no colocalization with gonadotropin-releasing neurons. 
Endocrinology 2001; 142: 573–579 
9.  Herbison AE, Theodosis DT. Immunocytochemical identification of oestrogen receptors 
in preoptic neurones containing calcitonin gene-related peptide in the male and female rat. 
Neuroendocrinlogy 1992; 56: 761–764 
10.  Lehman M, FJ Karsch. Do gonadotropin-releasing hormone, tyrosine hydroxylase-, and 
beta-endorphin-immunoreactive neurons contain estrogen receptors? A double-label 
immunocytochemical study in the Suffolk ewe. Endocrinology 1993; 133: 887–895 
11.  Reisine T, Bell GI. Molecular Biology of Somatostatin Receptors. Endocrine Reviews 
1995; 16: 427–442 
12.  Rotsztejn WH, Drouva S V, Epelbaum J, Kordon C. Somatostatin inhibits in vitro release 
of luteinizing hormone releasing hormone from rat mediobasal hypothalamic slices. 
Experimentia 1982; 38: 974–975 
13.  Bhattarai JP, Kaszás A, Park SA et al. Somatostatin inhibition of gonadotropin-releasing 
hormone neurons in female and male mice. Endocrinology 2010; 151: 3258–3266 
14.  Koyama M, Yin C, Ishii H, Sakuma Y. Somatostatin Inhibition of GnRH Neuronal 
59 
 
Activity and the Morphological Relationship between GnRH and Somatostatin Neurons in 
Rats. 2012; 153: 806–814 
15.  Herbison AE. Neurochemical identity of neurons expressing estrogen and androgen 
receptors in sheep hypothalamus. Journal of Reproduction and Fertility Supplement 1995; 
49: 371–383 
16.  Scanlan N, Dufourny L, Skinner DC. Somatostatin-14 neurons in the ovine hypothalamus: 
colocalization with estrogen receptor alpha and somatostatin-28(1-12) immunoreactivity, 
and activation in response to estradiol. Biology of reproduction 2003; 69: 1318–1324 
17.  Caraty A, Fabre-Nys C, Delaleu B et al. Evidence that the mediobasal hypothalamus is the 
primary site of action of estradiol in inducing the preovulatory gonadotropin releasing 
hormone surge in the ewe. Endocrinology 1998; 139: 1752–1760 
18.  Pillon D, Caraty A, Fabre-nys C et al. Regulation by Estradiol of Hypothalamic 
Somatostatin Gene Expression : Possible Involvement of Somatostatin in the Control of 
Luteinizing Hormone Secretion in the Ewe. Biology of Reproduction 2004; 44: 38–44 
19.  Fergani C, Routly JE, Jones DN et al. Activation of Cells Containing Estrogen Receptor 
Alpha or Somatostatin in the Medial Preoptic Area, Arcuate Nucleus, and Ventromedial 
Nucleus of Intact Ewes During the Follicular Phase, and Alteration after 
Lipopolysaccharide. Biology of Reproduction 2014; 91: 141–141 
20.  Van Vugt HH, Swarts HJM, Van de Heijning BJM, Van der Beek EM. Centrally applied 
somatostatin inhibits the estrogen-induced luteinizing hormone surge via hypothalamic 
gonadotropin-releasing hormone cell activation in female rats. Biology of Reproduction 
2004; 71: 38–44 
21.  Samuels MH, Henry P, Ridgway EC. Effects of Dopamine and Somatostatin on Pulsatile 
Pituitary Glycoprotein Secretion. Journal of Clinical Endocrinology and Metabolism 
1992; 74: 14–19 
22.  Prelevic GM, Wurzburger MI, Balint-Peric L, Nesic J. Inhibitory effect of sandostatin on 
seretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. The 
Lancet 1990; 336: 900–903 
23.  Hastie P, Evans N, Robinson J. Distribution of somatostatin receptors in the hypothalamus 
of control and prenatally androgenised ewes. In: Society of Endocrinology Annual 
Meeting Harrogate. 2009  
24.  Foradori CD, Goodman RL, Adams VL, Valent M, Lehman MN. Progesterone increases 
dynorphin A concentrations in cerebrospinal fluid, and preprodynorphin messenger 
ribonucleic acid levels in a subset of dynorphin neurons in the sheep. Endocrinology 2005; 
146: 1835–1842 
25.  Grachev P, Li XF, Hu MH et al. Neurokinin B signaling in the female rat: A novel link 
between stress and reproduction. Endocrinology 2014; 155: 2589–2601 
26.  Skinner DC, Harris TG, Evans NP. Duration and amplitude of the luteal phase 
60 
 
progesterone increment times the estradiol-induced luteinizing hormone surge in ewes. 
Biology of reproduction 2000; 63: 1135–1142 
27.  Nunn C, Schoeffter P, Langenegger D, Hoyer D. Functional characterisation of the 
putative somatostatin sst 2 receptor antagonist CYN 154806. Naunyn-Schmiedeberg’s 
Archives of Pharmacology 2003; 367: 1–9 
28.  Deaver DR, Stilley NJ, Dailey RA, Inskeep EK, Lewis PE. Concentrations of ovarian and 
pituitary hormones following prostaglandin F2 alpha-induced luteal regression in ewes 
varies with day of the estrous cycle at treatment. Journal of animal science 1986; 62: 422–
427 
29.  Watson RE, Wiegand SJ, Clough RW, Hoffman GE. Use of cryoprotectant to maintain 
long-term peptide immunoreactivity and tissue morphology. Peptides 1986; 7: 155–159 
30.  Lehman MN, Robinson JE, Karsch FJ, Silverman AJ. Immunoctochemical localization of 
luteinizing hormone-releasing hormone (LHRH) pathways in the sheep brain during 
anestrus and the mid-luteal phase of the estrous cycle. Journal of Comparative Neurology 
1986; 244: 19–35 
31.  Goodman RL, Lehman MN, Smith JT et al. Kisspeptin Neurons in the Arcuate Nucleus of 
the Ewe Express Both Dynorphin A and Neurokinin B. 2007; 148: 5752–5760 
32.  Merkley CM, Porter KL, Coolen LM et al. KNDy (kisspeptin/neurokinin B/dynorphin) 
neurons are activated during both pulsatile and surge secretion of LH in the ewe. 
Endocrinology 2012; 153: 5406–5414 
33.  Grachev P, Porter KL, Coolen LM et al. Surge-like Luteinizing Hormone Secretion 
Induced by Retrochiasmatic Area NK3R Activation is Mediated Primarily by Arcuate 
Kisspeptin Neurones in the Ew. Journal of Neuroendocrinology 2016; 28 
34.  Weems PW, Witty CF, Amstalden M et al. κ-opioid receptor is colocalized in GnRH and 
KNDy cells in the female ovine and rat brain. Endocrinology 2016; 157: 2367–2379 
35.  Merkley CM, Coolen LM, Goodman RL, Lehman MN. Evidence for Changes in Numbers 
of Synaptic Inputs onto KNDy and GnRH Neurones during the Preovulatory LH Surge in 
the Ewe. Journal of Neuroendocrinology 2015; 27: 624–635 
36.  Goodman RL, Coolen LM, Anderson GM et al. Evidence that dynorphin plays a major 
role in mediating progesterone negative feedback on gonadotropin-releasing hormone 
neurons in sheep. Endocrinology 2004; 145: 2959–2967 
37.  Goodman R, Legan S, Ryan K, Foster D, Karsch F. Importance of variations in 
behavioural and feedback actions of oestradiol to the control of seasonal breeding in the 
ewe. Journal of Endocrinology 1981; 89: 229–240 
38.  Thomas GB, Pearce DT, Oldham CM, Martin GB, Lindsay DR. Effects of breed, ovarian 
steroids and season on the pulsatile secretion of LH in ovariectomized ewes. Journal of 
reproduction and fertility 1988; 84: 313–324 
61 
 
39.  Goodman RL, Inskeep EK. Control of the Ovarian Cycle of the Sheep. In: Knobil and 
Neill’s Physiology of Reproduction. 2015; 1259–1305 
40.  Millar RP, Klaff LJ, Barron J, Levitt NS, Ling N. Somatostatin-28 inhibits LHRH-
stimulated gonadotropin secretion in man. Clinical Endocrinology 1982; 17: 103–107 
41.  Lightman SL, Fox P, Dunne MJ. THe Effect of SMS 201-995, a long-acting somatostatin 
analogue, on anterior pituitary function in healthy male volunteers. Scandinavian Journal 
of Gastroenterology 1986; 119: 84–95 
42.  Blache D, Fabre-Nys C, Venier G. Ventromedial hypothalamus as a target for oestradiol 
action on proceptivity, receptivity and luteinizing hormone surge of the ewe. Brain 
Research 1991; 546: 241–249 
43.  Meyer S L, Goodman RL. Separate Neural Systems Mediate the Steroid-Dependent and 
Steroid-Independent Suppression of Tonic Luteinizing Hormone Secretion in the 
Anestrous Ewe. Biology of Reproduction 1986; 571: 562–571 
44.  Whisnant CS, Goodman RL. Further Evidence That Serotonin Mediates the Steroid-
Independent Inhibition of Luteinizing Hormone Secretion in Anestrous Ewes. Biology of 
Reproduction 1990; 42: 656–661 
45.  Le Corre S, Chemineau P. Control of photoperiodic inhibition of luteinizing hormone 
secretion by dopaminergic and serotonergic systems in ovariectomized Ile-de-France ewes 
supplemented with oestradiol. Journal of reproduction and fertility 1993; 97: 367–373 
46.  Tillet Y. Immunocytochemical localization of serotonin-containing neurons in the 
myelencephalon, brainstem and diencephalon of the sheep. Neuroscience 1987; 23: 501–
527 
47.  Le Corre S, Chemineau P. Serotonergic 5HT2 receptors mediate the inhibitory action of 
serotonin on luteinizing hormone secretion in ovariectomized, estradiol-treated ewes that 
are refractory to short days. Biology of Reproduction 1993; 49: 140–147 
48.  Pelletier J, Auzan C, Daveau A, Clauser E, Chemineau P. Sheep 5HT2A receptors: Partial 
cloning of the coding sequence and mRNA localization by in situ hybridization in the ewe 
hypothalamus. Cell and Tissue Research 1999; 295: 231–239 
49.  Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology Classification 
of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacological Reviews 1994; 46: 
157–203 
50.  Legan SJ, Karsch FJ, Foster DL. The endocrine control of seasonal reproductive function 
in the ewe: a marked change in response to the negative feedback action of estradiol on 
lutienizing hormone secretion. Endocrinology 1977; 101: 818–824 
51.  Havern RL, Whisnantt CS, Goodman RL. Dopaminergic structures in the ovine 
hypothalamus mediating estradiol negative feedback in anestrous ewes. Endocrinology 
1994; 134: 1905–1914 
62 
 
52.  Billings HJ, Connors JM, Altman SN et al. Neurokinin B acts via the neurokinin-3 
receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep. 
Endocrinology 2010; 151: 3836–3846 
53.  Thiéry J, Martin G, Tillet Y et al. Role of Hypothalamic Catecholamines in the Regulation 
of Luteinizing Hormone and Prolactin Secretion in the Ewe during Seasonal Anestrus. 
Neuroendocrinology 1989; 49: 80–87 
54.  Goodman RL, Maltby MJ, Millar RP et al. Evidence that dopamine acts via kisspeptin to 
hold GnRH pulse frequency in check in anestrous ewes. Endocrinology 2012; 153: 5918–
5927 
55.  Smith JT, Clay CM, Caraty A, Clarke IJ. KiSS-1 messenger ribonucleic acid expression in 
the hypothalamus of the ewe is regulated by sex steroids and season. Endocrinology 2007; 
148: 1150–1157 
56.  Franceschini I, Lomet D, Cateau M et al. Kisspeptin immunoreactive cells of the ovine 
preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neuroscience 
Letters 2006; 401: 225–230 
57.  Foradori CD, Coolen LM, Fitzgerald ME et al. Colocalization of progesterone receptors in 
parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus. 
Endocrinology 2002; 143: 4366–4374 
58.  Boukhliq R, Goodman RL, Berriman SJ, Adrian B, Lehman MN. A subset of 
gonadotropin-releasing hormone neurons in the ovine medial basal hypothalamus is 
activated during increased pulsatile luteinizing hormone secretion. Endocrinology 1999; 
140: 5929–5936 
59.  Smith JT, Li Q, Yap KS et al. Kisspeptin is essential for the full preovulatory LH surge 
and stimulates GnRH release from the isolated ovine median eminence. Endocrinology 
2011; 152: 1001–1012 
60.  Lehman MN, Coolen LM, Goodman RL. Minireview: Kisspeptin/neurokinin B/dynorphin 
(KNDy) cells of the arcuate nucleus: A central node in the control of gonadotropin-
releasing hormone secretion. Endocrinology 2010; 151: 3479–3489 
61.  Ohkura S, Takase K, Matsuyama S et al. Gonadotrophin-releasing hormone pulse 
generator activity in the hypothalamus of the goat. Journal of Neuroendocrinology 2009; 
21: 813–821 
62.  Wakabayashi Y, Nakada T, Murata K et al. Neurokinin B and Dynorphin A in Kisspeptin 
Neurons of the Arcuate Nucleus Participate in Generation of Periodic Oscillation of 
Neural Activity Driving Pulsatile Gonadotropin-Releasing Hormone Secretion in the 
Goat. Journal of Neuroscience 2010; 30: 3124–3132 
63.  Rance NE, Krajewski SJ, Smith M a, Cholanian M, Dacks P. Neuroknin B and the 
Hypothalamic Regulation of Reproduction. Brain Research 2011; 1027: 116–128 
64.  Navarro VM, Gottsch ML, Chavkin C et al. Regulation of gonadotropin-releasing 
63 
 
hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of 








Figure 1. LH concentration patterns in 2 ewes receiving SSTR2 agonist, octreotide, injections 
(arrows) into the third ventricle. Black circles denote samples identified as pulses. Inset panels 
depict group mean (± SEM) LH concentration (MEAN), LH pulse amplitude (AMPL) and inter-
pulse interval (IPI) during 3 hrs pre- (open bars) and 7 hrs post- (black bars) injection. Statistical 
analysis was not performed because of the low number of animals and lack of contemporary 
vehicle control injection. 
Figure 2. Top panels, effect of SSTR2 agonist (Octreotide, black circles and bars) and vehicle 
(aCSF, open circles and bars) on the estrogen-induced LH surge. LH concentrations during E2-
induced LH surges in one animal are shown in the left panel; right panel presents mean (± SEM) 
LH surge amplitude, and time (hrs after E2 implants) of maximum LH value.  Bottom panels, 
effect of SSTR2 antagonist (CYN, black circles and bars) and vehicle (saline, open circles and 
bars) on the estrogen-induced LH surge. Left panel depicts LH concentrations during an E2-
induced LH surge in one control and two CYN-treated animals to illustrate variability in timing 
of the surge; right panel presents mean (± SEM) LH surge amplitude, and time of maximum LH 
values. 
Figure 3. Top, Representative LH concentration patterns in one anestrous intact ewe (left) and 
another luteal phase ewe (right) receiving either saline (top panels) or CYN (bottom panels) as 
icv injection (arrows). Black points represent samples identified as pulses. Note difference in y-
axes between seasons. Bottom panels, mean LH (± SEM) concentration during 2 hr pre- (open 
bars) and 4 hr post-injection (gray bars) sampling period for saline or CYN treatments are shown 
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on left and mean IPI (± SEM) during 4 hr sampling period after saline (open bars) or CYN (black 
bars) and shown on right. *, P<0.05 vs pre-injection period. 
Figure 4. Top panels, Percentage (± SEM) of GnRH and kisspeptin immunoreactive cells that 
contain c-Fos in ewes that received either saline (open bars)  or CYN (black bars). *, P<0.05 vs 
saline treated ewes. DBB: Diagonal band of Borca; AHA: anterior hypothalamic area. Lower 
panels, Representative photomicrographs of GnRH (mediobasal hypothalmus, middle) and 
kisspeptin (caudal ARC, bottom) immunoreactive soma (brown)  in ewes treated with CYN (left) 
or saline (right). Arrow heads indicate GnRH or kisspeptin soma  that contain nuclear  c-Fos 
(black). Scale bar, 50  µm. 
Figure 5. Top panels, Representative LH patterns in one OVX ewe during anestrus (left) and 
another ewe in the breeding season (right) receiving icv injection (arrows) of  saline  (top 
panels), or CYN (bottom panels). Black points represent samples identified as pulses. Bottom 
panels, mean (± SEM) IPI (left panel) and mean LH concentration (right panel) during 4 hr post-
injection period in OVX ewes receiving saline (open bars) and CYN (black bars) during anestrus 
(left) or the breeding season (right). *, P<0.05 vs saline injection. 
Figure 6. Change in mean LH concentration following CYN injection in intact anestrus ewes 
(Exp 3) versus chronic cannula position (distance from tip of cannula to infundibular recess on 
the lateral radiograph taken during neurosurgery).  
Figure 7. Proposed model for SST action within the hypothalamus that mediates the steroid-
independent control of LH secretion in sheep between the anestrous (left) and the breeding 
seasons (right). The inhibitory photoperiod in anestrus stimulates  serotonergic neurons that 
increase the activity of SST neurons in the VMN.  These SST neurons in turn inhibit GnRH 
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pulse frequency, which could be mediated  directly on GnRH neurons, indirectly through KNDy 
neurons, or indirectly through someother neuron type. This system is distinct from the steroid-
dependent actions of photoperiod which act via A15 dopaminergic (DA) neurons. See text for a 























































Table 2: Number of GnRH and kisspeptin immunoreactive cells 
GnRH DBB POA AHA MBH 
Saline 7.0 ± 2.9 65.5  ± 18.2 25.5  ± 5.2 51  ± 8.9 
CYN 6.8  ± 2.9 74.5  ± 13.8 22.3  ± 6.4 27.8 ± 4.3 
Kisspeptin POA Rostral ARC Middle ARC Caudal ARC 
Saline 10.9  ± 5.89 16.7  ± 7.1 65.5  ± 11.2 46.1  ± 14.2 
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Gonadotropin secretion is regulated by ovarian steroids and steroid independent factors. The 
neuropeptide kisspeptin is critical for gonadotropin secretion in many species. Several lines of 
evidence support the hypothesis that the neuropeptide somatostatin (SST) also contributes to the 
regulation of gonadotropin secretion. We recently demonstrated that a SST receptor 2 antagonist 
stimulates mean LH secretion in ovary intact ewes. To investigate potential sites for SST action 
in the ovine hypothalamus we used immunohistochemistry to determine whether cells that 
produce kisspeptin (KNDy cells in the arcuate nucleus) or GnRH receive direct synaptic contact 
from SST fibers, and whether the number of these inputs changes throughout the estrous cycle or 
by season. The majority of KNDy cells receive synaptic input (evident by presynaptic 
synaptophysin immunostaining) from SST cells, but the amount of these inputs did not differ 
among phases of the estrous cycle or season. A subset of GnRH cells in both the preoptic area 
(POA) and mediobasal hypothalamus also receive structural synaptic input from SST cells. A 
greater percentage of POA GnRH cells had SST synapses during the surge than in anestrus, the 
luteal or early follicular phase of the estrus cycle. The total number of synaptic inputs onto 
GnRH and KNDy cells was altered by phase of the estrous cycle and season, extending the 
hypothesis that changes in GnRH and KNDy cell synaptic connectivity may contribute to altered 






The pattern of LH and GnRH secretion is regulated by ovarian steroids as well as steroid 
independent factors. Sheep, like most mammals, display seasonal alterations in reproductive 
performance, which in part reflect activation of different negative feedback systems. During the 
breeding season pulsatile GnRH and LH secretion are regulated by estradiol (to suppress pulse 
amplitude) and progesterone (to suppress pulse frequency) (1). However during the non-breeding 
season (anestrus) estradiol inhibits LH pulse frequency, which prevents ovulation (2). The neural 
substrates that mediate these feedback effects must be steroid sensitive (i.e. contain steroid 
receptors), since GnRH neurons do not contain estrogen receptor alpha (ERα) or progesterone 
receptor (3,4); they are therefore dependent on neural afferents for information on changes in 
steroid levels. Two populations of kisspeptin cells in the hypothalamus are important for 
gonadotropin secretion. The kisspeptin cells in the arcuate nucleus contain NKB and dynorphin 
(5) (known as KNDy neurons), as well as ERα (6) and progesterone receptors (7), and are 
thought to underlie GnRH pulse generation (8–12) and contribute to LH surge generation 
(13,14). The second population of kisspeptin neurons, located in the preoptic area (POA) also 
contain ERα (6) and are likely only involved in LH surge generation (13–15). However, an 
extensive body of research has implicated a number of other signaling molecules in the 
regulation of gonadotropin secretion (16). 
The hypothalamic peptide somatostatin (SST) has been demonstrated to suppress 
pulsatile LH secretion in sheep (17) and humans (18). SST also inhibited GnRH release from rat 
hypothalamic explants (19), and suppressed GnRH spike firing in mice and rats (20,21). Among 
the five SST receptor isoforms, SSTR2 is a logical candidate to mediate these effects: the SSTR2 
agonist (octreotide) blunted the LH surge in rats (22) and suppressed pulsatile LH secretion in 
78 
 
humans (23). Additionally, preliminary evidence indicates that GnRH cells within the POA 
contain SSTR2 (but not the other receptors) immunoreactivity (24). POA GnRH cells in mice 
contain mRNA for only SSTR2 (20) whereas rat POA GnRH cells contain only modest 
expression for all 5 receptors subtypes (21). Our group recently used a SSTR2 antagonist to 
demonstrate an endogenous role for SST acting via SSTR2 to suppress pulsatile LH secretion 
(Chapter 2). The SSTR2 antagonist increased mean LH secretion in intact animals during both 
anestrus and the breeding season, though the magnitude of the response in anestrus was larger. 
Additionally, we found that application of the antagonist to anestrous ewes increased c-Fos 
expression in a subset of GnRH neurons (only in the mediobasal hypothalamus [MBH]) and in 
kisspeptin neurons in the caudal aspect of the ARC. Although these neurons were considered 
activated, it could not be determined whether SST acts directly on them or if they are activated 
indirectly via interneurons. Stimulatory effects of the SSTR2 antagonist were also seen in OVX 
ewes in the non-breeding season. The antagonist was given into the third ventricle, therefore the 
specific site of action could not be determined, but indirect evidence supports the possibility that 
SST acts within the MBH to suppress gonadotropin secretion (Chapter 2). 
To investigate potential sites for SST action in the ovine hypothalamus we used 
immunohistochemistry to determine whether KNDy cells and GnRH cells receive direct synaptic 
contact from SST fibers. The number of unidentified synaptic inputs onto GnRH cells differs 
with season and stage of the estrous cycle (25–27). Similarly, the number of synaptic contacts 
onto KNDy cells also differs throughout the estrous cycle (25). In light of the reports that 
synaptic inputs to GnRH and KNDy cells do change and may contribute to differences in 
gonadotropin secretion, we compared the number of SST synaptic contacts onto GnRH (both 
POA and MBH) and KNDy neurons in intact sheep during the breeding season (luteal phase, 
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early follicular phase and during the surge) and anestrus. The total number of synaptic contacts 
and the number of synaptic contacts by SST fibers was determined using triple label 
immunofluorescence (antibodies for SST, synaptophysin [a protein that is expressed exclusively 
in the presynaptic terminal], and either GnRH or NKB [a marker for KNDy cells]) and confocal 
microscopy. Immunohistochemistry for a marker of the presynaptic terminal (i.e. synaptophysin) 
and confocal microscopy has been proven to identify the same synapses as electron microscopy 
(28). To further characterize the neural substrates by which SSTR2 blockade stimulates LH we 
sought to describe SSTR2 immunoreactivity throughout the ovine hypothalamus and determine 
whether GnRH or KNDy cells contain SSTR2. 
MATERIALS & METHODS 
 
Animals 
Mature multiparous ewes (>2yrs) were used. Animals were maintained indoors under 
artificial light that was adjusted every other week to match natural light periods. Ewes were fed a 
maintenance diet of cubed alfalfa and had free access to mineral blocks and water. Experiments 
were conducted in June (anestrus) and in October and November (breeding season). All 
procedures were approved by the West Virginia University Animal Care and Use Committee and 
were in accordance with the NIH guidelines for the care and use of research animals. 
Experiment 1: Do SST fibers synapse onto GnRH and KNDy cells? 
Animal Protocol 
Adult, ovary-intact ewes were randomly assigned for tissue collection during the luteal 
phase (n=5), early follicular phase (n=5) or during the preovulatory LH surge (n=5). Estrus 
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cycles were synchronized using well established methods (29). Briefly, animals received 2 
injections of prostaglandin F2α (PGF2α; 5 mg each 3 hrs apart; Lutalyse, (Zoetis, Parsippany, NJ) 
and 2 intravaginal progesterone containing CIDRs after the second injection. Eight days later, 
PGF2α was injected (5 mg each 3 hrs apart) and CIDRs were removed from all sheep; 24 hrs 
later, 5 sheep were euthanized after blood collection described below (“early follicular phase” 
group). Five days later the remaining 10 sheep received 2 intravaginal CIDRs. Five days after 
CIDR insertion, 5 sheep were bled and then euthanized (“luteal phase” group). CIDRs were 
removed from the remaining 5 ewes 7 days after CIDR insertion, and were euthanized 60 hr later 
(LH surge group). Jugular blood samples (3-4mL) were collected at 12 min intervals for 4 hrs 
before euthanasia from animals in the follicular and luteal phase groups. Jugular blood samples 
were collected at 4 hr intervals beginning 36 hrs after CIDR removal until the time of euthanasia 
in the surge group and assayed for LH. Additionally tissue was collected from 4 intact anestrous 
ewes during a previous experiment as described in Chapter 2. 
Blood sampling & assay 
Blood samples were collected by jugular venipuncture into heparinized tubes. Plasma 
was harvested and stored frozen until assayed for LH. Plasma samples (50-200μL aliquots) were 
assayed in duplicate for LH using a double liquid phase radioimmunoassay that has been 
previously validated for use in sheep (30). Assay reagents were acquired from the National 
Hormone and Peptide Program and LH concentrations are expressed in terms of NIH S24. The 
sensitivity of the LH assays averaged 0.10 ± 0.02 ng/mL and the inter- and intra- assay 
coefficients of variation were 6.9% and 5.1%, respectively. LH pulses were detected as described 
previously (1). LH concentrations at the time of euthanasia, and inter-pulse interval and pulse 
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amplitude during the four hours before euthanasia (for animals collected during the early 
follicular phase, luteal phase and anestrus) are shown in Table 1. 
Neural tissue collection & processing  
Ewes were treated with heparin (20,000 U) 10 min before and at the time of euthanasia, 
which was performed with an overdose (8-16mL, iv) of sodium pentobarbital (Euthasol, 
Patterson, Columbus, OH). The head was rapidly removed and perfused with 6L of 4% 
paraformaldehyde in 0.1M phosphate buffer (PB) with 0.1% NaNO3. A block of tissue including 
the hypothalamus and POA was removed and stored overnight in the same paraformaldehyde 
solution at 4°C. Tissue was then transferred to 20% sucrose solution in PB and maintained at 
4°C. After sucrose infiltration, tissue was frozen and 45μm-thick-coronal sections were cut using 
a microtome with a freezing stage, collected in 10 series (450μm apart), and stored at -20°C in 
cryoprotectant solution (31). 
Immunohistochemistry 
To determine whether the abundant SST fibers that have been reported previously (32,33) 
within the ovine hypothalamus synapse onto GnRH or KNDy cells we employed 
immunohistochemistry to detect SST, synaptophysin (presynaptic marker), and GnRH or NKB; 
because antibodies against SST, GnRH, and NKB were made in rabbits, TSA-amplification was 
used with the latter two antisera. For detection of GnRH or NKB, antisera were used at very low 
concentrations and detected with tyramide amplification, a procedure that has been shown to 
prevent cross reactivity (34). Nissl staining was used to identify GnRH or NKB cell boundaries. 
The number of SST synapses onto GnRH cells was determined in 1-2 hemisections from the 
POA and 4-8 hemisections from the MBH. Tissue was rinsed in PB 8 times (15 min each), stored 
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overnight in PB at 4°C, and rinsed 12 additional times in PB with 0.9% saline (PBS; 15 min 
each). Tissue was incubated in 1% H2O2 in PBS for 10 min, rinsed, then incubated in 4% normal 
goat serum (NGS; Jackson Immunoresearch, West Groove, PA) in PBS with 0.04% triton X-100 
(PBST) for 1 hr followed by rabbit anti-GnRH serum (dilution: 1:3000 with 4% NGS in PBST; 
cat: 20075; Immunostar, Hudson, WI) for 17hrs. Tissue was rinsed with PBS and incubated 
sequentially in biotinylated goat anti-rabbit IgG (dilution: 1:500 in PBST with 4% NGS; Vector 
labs, Buringame, CA) for 1 hr, in ABC-elite (dilution: 1:500 in PBS; Vector Labs) for 1hr, in 
biotinylated tyramide  (1:250 in PBS with 1uL of 3% H2O2 per mL; Perkin Elmer, Bridgeville, 
PA) for 10 min, and in Alexa 555 streptavidin (dilution: 1:200; S32355; Invitrogen, Carlsbad, 
CA) for 1 hr, with intervening rinsing steps. Tissue was rinsed and incubated in 4% NGS in 
PBST for 1 hr and then placed in rabbit anti-SST serum (dilution 1:500; T-4103; Peninsula 
Laboratories, San Carlos, CA) and monoclonal mouse anti-synaptophysin (dilution 1:200; 
S5768; Sigma-Aldrich, Saint Louis, MO) with 4% NGS in PBST for 17 h. Tissue was rinsed and 
sequentially incubated with Dylight 488 goat anti-mouse IgG (dilution 1:200 in 4% NGS in 
PBST, 35503,  Invitrogen) and Alexa 647 goat anti-rabbit IgG (dilution 1:200 with 4% NGS in 
PBST, A-21245, Invitrogen) for 1 hr each with intervening rinsing steps. Finally, tissue was 
incubated in Neurotrace 435/455 (dilution 1:200 in PBS, N21479, Invitrogen). Tissue was 
mounted on superfrost slides (Fisher Scientific, Pittsburgh, PA) and cover glass was applied with 
gelvatol (35). Antibodies for GnRH (36) , NKB (37), synaptophysin (38) and SST (32) have 
been used previously in sheep tissue.  
The number of SST synapses onto KNDy cells was determined in 1-2 hemi-sections from 
each the middle and caudal aspects of the ARC. Immunohistochemistry was performed 
identically as described for SST synapses onto GnRH cells, except that rabbit anti-NKB serum 
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(dilution 1:10,000 with 4% NGS in PBST, G-046-26; Phoenix Pharmaceuticals, Burlingame, 
CA) was used in place of the rabbit anti-GnRH serum.  
Confocal analysis 
All confocal images were acquired with a Nikon A1R laser-scanning microscope (Nikon 
Instruments, Tokyo, Japan) with a 60x objective (aperture: 1.4). Nissl, Dylight 488, Alexa 555, 
and Alexa 647 were imaged with 405, 488, 561 and 640 nm lasers, respectively. For GnRH or 
NKB, 7-11 neurons with complete cell bodies were randomly selected from each region for 
analysis per animal. Confocal images were taken at 0.5 μm intervals in the z-axis. In each section 
the number of SST close-contacts onto either GnRH or NKB cell bodies or proximal dendrites 
was enumerated. The SST varicosities that contained synaptophysin were also counted and were 
considered SST synapses onto GnRH or NKB cells (28); single labeled synaptophysin contacts 
onto GnRH or NKB cells were also counted. To be considered a close contact the SST or 
synaptophysin staining had to be in direct contact (no intervening dark pixels) with GnRH, NKB 
or Nissl staining that also contained either GnRH or NKB. To minimize the risk of over-
counting, markers were placed on contacts as they were counted. Analysis was performed with 
ImageJ software following minor adjustments to brightness and contrast. GnRH and NKB cell 
size was estimated by the number of optical sections required to image the entire cell; these did 
not differ among treatment groups (data not shown). 
The percentage of GnRH and NKB cells that had SST or dual-labeled SST and 
synaptophysin contacts was determined in each region by an experimenter blinded to treatments. 
For cells that had SST or dual-labeled SST and synaptophysin contacts, the number of each type 
of contact was enumerated and averaged for each animal. For each GnRH and NKB cell, the 
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number of SST close contacts, SST synapses, total number of synapses (synaptophysin, 
independent of presence of SST) and percentage of cells that had SST contacts or SST synapses 
within each region were compared among treatment groups with one-way ANOVA. Where 
appropriate, Tukey’s multiple comparisons test was used to determine differences among 
treatment groups. P < 0.05 was considered statistically significant. Data are presented as mean ± 
SEM. 
Experiment 2: Do GnRH or KNDy cells contain SSTR2? 
The antiserum raised against SSTR2 that had been used in sheep neural tissue previously 
by other workers (24) had been discontinued by the supplier. Consequently we sought to identify 
an antibody suitable for detection of SSTR2 in ovine tissue; using the criteria that: 1) the 
antibody must produce reliable immunostaining, 2) preadsorption of the antibody with the 
immunogenic peptide must prevent immunostaining, and 3) western analysis must yield band(s) 
of the predicted size. We screened four commercially available antisera listed in Table 3, using 
an immunoperoxidase protocol. As most commercially available antisera are raised against 
human or rodent SSTR2, we selected antisera whose antigenic sequence was homologous to the 
ovine SSTR2 sequence for screening. All steps were performed at room temperature with mild 
agitation, unless noted differently. Tissue was rinsed in 0.1M PB overnight, thoroughly rinsed in 
PBS, incubated in H2O2, then blocking solution containing 4% NGS, then incubated for 17 hrs in 
one of the SSTR2 antisera (dilutions tested listed in Table 3) with 4% NGS in PBST. Tissue was 
then incubated sequentially in biotinylated goat anti-rabbit IgG  (dilution: 1:500 in PBST with 
4% NGS) and ABC-elite (dilution 1:500 in PBS) for one hour each with intervening PBS rinse 
steps and then incubated in 3,3’-diaminbenzidene (10mg per 50mL PB with 20μL of 30% H2O2, 
Sigma-Aldrich, Saint Louis, MO) for 10 min, rinsed with PB and mounted on superfrost slides 
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(Fisher Scientific). Once dried, cover glass was applied with Eukitt mounting media (Fisher 
Scientific). Additionally, for each antisera, the immunohistochemistry protocol described above 
was repeated following antigen retrieval. Following initial rinsing steps, tissue was incubated for 
20 min at 80°C in unmasking solution (Vector Laboratories) then allowed to cool for 30 min and 
rinsed with PBS. 
To test for antibody specificity, peptide-blocking controls were performed. The antiserum 
was incubated with the immunogenic peptide (5-10 times more peptide than antiserum by 
weight; supplied by the respective vendor) for 24 hr at 4°C. Immunohistochemistry was 
performed as described above using either the pre-adsorbed antiserum or antiserum incubated 
with PBS (equal volume to blocking peptide). Slides were prepared and staining was visualized 
with a bright field microscope (Axiovert 400CFL, Zeiss) with a 20x objective. 
RESULTS 
 
Experiment 1: SST synaptic input to GnRH and KNDy neurons 
SST synapses onto GnRH cells based on presynaptic synaptophysin immunostaining 
were evident in both the MBH (Fig 1) and POA (Fig 2). In the MBH, the majority of GnRH cells 
had SST close contacts, whereas fewer GnRH cells had contacts that colocalized SST and 
synaptophysin (SST+synap) (Table 4). Neither the percentage of GnRH cells that had SST or 
SST+synap close-contacts, nor the number of SST or SST+synap close-contacts per cell differed 
among groups. The total number of synaptophysin contacts on MBH GnRH cells was 
numerically lower in anestrus than any stage of the estrous cycle (Table 6), but this difference 
did not reach statistical significance (P=0.09). 
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In the POA, SST and SST+synap close-contacts were evident on some GnRH cells. The 
percentage of GnRH cells that had dual-labeled SST and synaptophysin close-contacts differed 
among groups such that a greater percentage of GnRH cells received SST+synap contacts during 
the LH surge than all other groups (Table 4). However, the number of SST+synap close-contacts 
per cell did not differ among groups. The total number of synaptophysin contacts on POA GnRH 
cells was significantly greater in animals during the LH surge than in animals during anestrus 
(Table 6).  
Not all tissue has been analyzed for NKB-SST-Synaptophysin staining at this time; these 
data are from the following number of animals, anestrus:  n=3, luteal: n=4, early follicular: n=5, 
luteal: n=4), 6-11 cells each. 
SST+synap close-contacts were present on the majority of NKB cells in both the middle 
and caudal aspects of the ARC (Fig 3). Neither the percentage of NKB cells that had SST or 
SST+synap close-contacts, nor the number of these contacts per cell, differed among treatment 
groups (Table 5). The total number of synaptophysin contacts on NKB cells was significantly 
greater in surge animals than in anestrous animals in the middle ARC (Table 6). Similarly in the 
caudal ARC, the total number of synaptophysin contacts on NKB cells was significantly greater 
during the LH surge than during the early follicular phase of the estrous cycle. It should be noted 
that in both regions of the ARC, the total number of synaptophysin contacts on NKB cells during 
the LH surge was numerically greater than all other groups, though some of these comparisons 
did not reach statistical significance. As expected, the majority of NKB cells in both middle and 
caudal ARC had dual-labeled NKB and synaptophysin contacts (82-98%). The percentage of 
these contacts did not differ among treatment groups, however the number of these contacts per 
NKB cell did differ among groups such that there were more of these contacts during the LH 
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surge than the luteal phase in the middle ARC, and during LH surge than the early follicular 
phase in the caudal ARC (Figure 4).  
Experiment 2: SSTR2 immunoreactivity in the ovine hypothalamus 
None of the antibodies tested met the criteria for acceptable use in sheep neural tissue. 
One antiserum (ASR-002) failed to produce any immunostaining at any concentration. Another 
antiserum (SC25676) produced light, but detectable immunostaining in the POA resembling 
neurons and very faint fiber-like staining in the MBH. Peptide-blocking controls could not be 
performed because the immunogenic peptide was not available from the supplier and custom 
synthesis of the immunogenic peptide was prohibitively expensive. Because this critical test of 
the antibody could not be performed, no further investigation of this antiserum was performed. 
The third antiserum from Alomone labs (ASR-006) produced robust and vibrant immunostaining 
in the POA and MBH (with intense staining in the ARC). However, the pattern of 
immunostaining did not resemble neurons, instead appeared as a glia-like pattern (resembling 
staining for glial fibrillary acidic protein). Furthermore, pre-adsorption of the antiserum with the 
immunogenic peptide did not prevent immunostaining. The final antiserum tested (Orb11422) 
produced reliable immunostaining of neurons in the POA and a dense punctate staining in the 
ARC, however pre-adsorption of the antiserum with the immunogenic peptide did not reduce 
immunostaining. Because an acceptable antiserum against SSTR2 was not identified, we could 
not describe SSTR2 immunoreactivity throughout the ovine hypothalamus or determine whether 






This report demonstrates that both GnRH and KNDy cells have recieve synaptic input 
from SST cells. We observed abundant SST synapses onto GnRH cells which has been observed 
in mice (20), but not rats (21). Though these contacts were observed, only minor neuro-plasticity 
of SST inputs to GnRH or KNDy cells was detected. A greater percentage of POA GnRH cells 
had SST synapses (evident by presynaptic synaptophysin immunostaining) during the surge than 
in anestrus, the luteal or early follicular phase of the estrus cycle. Despite relatively few changes 
in SST synaptic inputs, we did observe changes in overall synaptic inputs to GnRH and KNDy 
cells evident by changes in the total number of synaptophysin contacts onto these cells which is 
consistent with previous reports of altered synaptic contacts onto GnRH and KNDy cells (25–
27,39). 
Pharmacological experiments in sheep have demonstrated that SST suppresses pulsatile 
LH secretion (17) and that a SSTR2 antagonist stimulates pulsatile LH secretion (Chapter 2). In 
both of these reports, the drugs were administered into the third ventricle which does not provide 
information about the site of action. However two lines of evidence support the hypothesis that 
SST acts in the MBH. First, animals with cannulae placed more caudally in the ventricle (further 
from the POA) had a larger increase in mean LH concentrations in response to the SSTR2 
antagonist than animals with cannulae placed more rostrally. Second, SSTR2 blockade increased 
c-Fos expression in a subset of GnRH neurons in the MBH and kisspeptin neurons in the caudal 
ARC. The presence of SST synaptic contacts onto both MBH GnRH cells and KNDy cells is 
consistent with the possibility that endogenous SST acts in the mediobasal hypothalamus to 
suppress LH secretion. In the present study we found that 23 ± 4% of GnRH cells in the MBH 
had SST synapses in anestrus ewes, which is quite similar to the 24 ± 5% of GnRH cells that 
89 
 
contained c-Fos after SSTR2 antagonist administration during anestrus. Thus it is possible that 
SST acts directly on a subset of GnRH cells in the MBH to regulate pulsatile LH secretion. 
Pulsatile LH release in sheep is likely mediated by a subset of GnRH neurons within the MBH 
because administration of an opioid antagonist or pheromonal stimuli, which stimulate pulsatile 
LH secretion, increased c-Fos expression only in GnRH cells in the MBH (40). 
Electrophysiological data in rodents also supports the possibly of direct action of SST on GnRH 
cells (20,21).  
It is also possible, but not mutually exclusive, that SST acts via the KNDy cells in the 
ARC that are implicated in GnRH pulse generation (8–12). Though we previously observed only 
a modest increase in c-Fos expression in KNDy cells in the caudal aspect of the ARC, the 
majority of the KNDy cells in the middle and caudal ARC received synaptic inputs from SST 
cells. A few possibilities for this disparity exist. First, c-Fos expression may not be an effective 
indicator of cellular activation induced by SSTR2 blockade. Second, endogenous SST may also 
act via the other SST receptors since the type of these receptors in KNDy neurons has not been 
determined. Finally, the methods employed here (immunohistochemistry and confocal 
microscopy) are useful for assessing the presence of synapses, but synapse function (i.e. the 
ability of one cell to alter the activity of another cell) cannot be inferred from this method.    
 Administration of an SSTR2 antagonist to both luteal phase and anestrous ewes 
stimulated LH secretion, though the magnitude of response was greater during anestrus (Chapter 
2). We therefore expected that during anestrus, we would observe more SST synaptic input to 
GnRH and KNDy reflecting a greater inhibitory tone than during the breeding season. Though 
not statistically significant, a greater percentage of GnRH cells in the MBH had SST synapses in 
anestrus (23 ± 4%) than in the luteal phase of the estrous cycle (14 ± 6%). Additionally, it is 
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possible that GnRH and/or KNDy cells are also more sensitive to the SST input during anestrus, 
possibly by increased receptor or intra-cellular signaling molecule content. 
 Previous studies have identified an increase in the total number of synaptic contacts onto 
GnRH cells during the breeding season compared to anestrus (26,27). We detected a similar 
pattern in which GnRH cells in the MBH had fewer total synaptic contacts during anestrus than 
during the breeding season (though only the comparison to the surge group was statistically 
significant). However, this pattern was not apparent for GnRH cells in the POA. These 
differences may stem from the endocrine condition of animals, Jansen et al. used (26) OVX+E2 
ewes (26), whereas we used ovary intact animals in the present study. Moreover the method used 
to detect synapses (electron microscopy) by Xing et al.(27) differed from confocal microscopy 
used here. However immunohistochemistry for a presynaptic marker and confocal microscopy 
and electron microscopy have been shown to identify the same synapses (28). In addition to the 
number of synapses, differences in the type of synapses onto GnRH cells have been reported, 
with a net increase in stimulatory contacts during the breeding season (26). Thus changes in 
absolute number of synapses must be interpreted cautiously.  
Surprisingly the number of NKB containing synapses onto NKB cells was not lowest 
during anestrus, when LH secretion is suppressed. Instead, the number of these contacts is 
comparable to that during the LH surge. This may reflect the importance of these connections to 
pulse generation. There also may be an increase in the number of inhibitory synapses onto KNDy 
cells during anestrus, whereas there is an increase in stimulatory inputs during the LH surge 
compared to the luteal phase (25). A likely source of inhibitory inputs during anestrus is the A15 
dopaminergic neurons (41–45) which project to the MBH (43). In anestrus, E2 acts in the RCh 
(46) and the POA (47) to suppress LH via A15 dopaminergic neurons. KNDy cells in the ARC 
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contain the relevant dopamine receptor (D2R) and local blockade of D2R stimulates LH in a 
kisspeptin dependent manner (48). Thus, the increase in the total number of synaptic inputs onto 
KNDy cells during anestrus may reflect an increase in inhibitory dopamine inputs to suppress 
LH secretion. 
The percentage of GnRH cells within the POA that had SST synapses was greater during 
the surge than in all other groups. Increased innervation by fibers containing an inhibitory 
molecule was not expected during the massive discharge of GnRH that occurs to elicit the LH 
surge. In addition, neither an SSTR2 agonist nor antagonist altered LH surge secretion (Chapter 
2). A few possibilities could explain these differences. First, SST could act via a different 
receptor on GnRH cells, however this is unlikely because POA GnRH cells only contain SSTR2 
(and not the others) (24). Second, during the LH surge the stimulatory input(s) to GnRH cells 
likely overpower and obviate any effects of SST. Another possibility is that these SST-
containing synapses onto GnRH cells also contain additional neurotransmitters that do stimulate 
the GnRH cells. The origin of the SST fibers that synapse onto GnRH cells in not known, but 
may be the SST cells in the VMN. Reciprocal tract-tracing experiments have demonstrated that 
soma in the VMN project to the POA, which raises the possibility that SST cells in the VMN 
project onto GnRH neurons in the POA (49,50). The population of SST cells in the VMN has 
been implicated in the LH surge as two studies have reported an increase in c-Fos in  these cells 
during the LH surge (51,52), which would be consistent with the increase in percentage of GnRH 
cells that receive SST synapses in this study. 
In this study, we observed numerous SST close contacts onto GnRH or KNDy cells that 
did not also contain synaptophysin. The simplest explanation is that these SST fibers are indeed 
in close proximity, but do not actually form synapses onto GnRH or KNDy cells. Some technical 
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limitations may also contribute to this finding. First, the synaptophysin protein that may actually 
be present in the close contacts containing SST but is below the limit of detection by the 
antibody. Additionally, the SST antiserum which is co-incubated with the synaptophysin 
antiserum may further obfuscate detection of synaptophysin. Nevertheless, the dual-labeled SST 
and synaptophysin close contacts demonstrate the presence of synapses, though may 
underestimate the number of SST synapses onto GnRH or KNDy cells.  
To further characterize possible sites for SST action in the hypothalamus, 
immunostaining for SSTR2 was planned. However, the lack of suitable antibody precluded these 
experiments.  Detection of G protein coupled receptors with antibodies can be difficult due to the 
fact that the majority of the protein is situated within the plasma membrane and therefore 
unavailable for antibody interactions. Additionally, these receptors tend to be expressed in low 
copy numbers further obfuscating immuno-detection. Selection of commercial antiserum were 
based on published antigenic sequences that were similar to the sheep SSTR2 protein.  Future 
work could employ in situ hybridization to detect mRNA for sstr2 in the ovine tissue.  
  In summary, these experiments provide evidence for somatostatinergic synapses onto 
GnRH and KNDy neurons within the ovine hypothalamus. The total number of synaptic inputs 
onto GnRH and KNDy cells was altered by phase of the estrous cycle and season, extending the 
hypothesis that changes in the GnRH and KNDy cell synaptic connectivity may contribute to 
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Figure 1: SST and Synaptophysin contacts onto a GnRH  neuron in the MBH. Confocal image 
(0.5µm optical thickness). Upper left, GnRH; upper right, synaptophysin; lower left, SST; lower 
right, merge: nissl (blue), synaptophysin (green), NKB (red), SST (magenta). Bar = 10 µm. 
Figure 2: SST and Synaptophysin contacts onto an NKB neuron in the POA. Confocal image 
(0.5µm optical thickness). Upper left, GnRH; upper right, synaptophysin; lower left, SST; lower 
right, merge: nissl (blue), synaptophysin (green), NKB (red), SST (magenta). Bar = 10 µm. 
Figure 2: SST and Synaptophysin contacts onto an NKB neuron in the caudal ARC. Confocal 
image (0.5µm optical thickness). Upper left, NKB; upper right, synaptophysin; lower left, SST; 
lower right, merge: nissl (blue), synaptophysin (green), NKB (red), SST (magenta). Bar = 10 
µm. 
Figure 4: Total number of synaptophysin contacts onto NKB cells (Mean ± SEM) in the middle 






Table 1. LH concentrations at the time of euthanasia, inter-pulse interval and pulse amplitude 
 Anestrus Luteal Early Follicular Surge 
Concentration at time 
of euthanasia, ng/mL 
5.5 ± 2.4 1.14 ± 0.3 3.1 ± 1.1 21.9 ± 11.93 
Inter-pulse interval, min 121.5 ± 34.5 115.2 ± 8.9 46 ± 3.2 n/a 









































































































































Table 4: Percentage of GnRH with single and dual-labeled SST contacts and number of single 
and dual-labeled SST contacts onto GnRH cells 
 Anestrus Luteal Early Follicular Surge 
MBH     
    % of cells  w/SST 81.9 ± 11.0 76.6 ± 5.6 75.0 ± 9.6 84.0 ± 2.4 
    # of SST/cell 3.1 ± 0.6 2.8 ± 0.5 2.3 ± 0.3 3.2 ± 0.4 
    % w/SST+Synaptophysin 23.1 ± 4.5 13.9 ± 5.7 20.0 ± 4.1 32.0 ± 5.8 
    # of SST+Synaptophysin 1.1 ± 0.1 2.2 ± 0.5 1.8 ± 0.4 2.7 ± 0.4 
     
POA     
    % of cells  w/SST 75 ± 6.5 63.5 ± 13.7 52.4 ± 7.6 70.6 ± 4.4 
    # of SST/cell 2.6 ± 0.4 2.1 ± 0.2 2.0 ± 0.2 2.9 ± 0.5 
    % w/SST+Synaptophysin 10 ± 4.1 a 8 ± 3.7 a 14.5 ± 5.0 a 34.7 ± 3.0 b 
    # of SST+Synaptophysin 1.7 ± 0.7 1.2 ± 0.2 1.0 ± 0 1.1 ± 0.1 








Table 5: Percentage of NKB with single and dual-labeled SST contacts and number of  single 
and dual-labeled SST contacts onto NKB cells 
 Anestrus Luteal Early Follicular Surge 
Middle ARC     
    % w/SST 100.00% 82.9 ± 11.9 90.0 ± 4.1 97.2 ± 2.7 
    # of SST 4.9 ± 2.7 7.6 ± 0.23 3.9 ± 0.53 8.2 ± 1.84 
    % w/SST+Synaptophysin 77.9 ± 5.7 89.3 ± 6.4 80.8 ± 10.8 61.1 ± 7.3 
    # of SST+Synaptophysin 2.2 ± 0.19 3.6 ± 0.85 3.9 ± 0.59 2.8 ± 0.42 
Caudal ARC     
    % w/SST 88.3 ±7.3 86.6 ± 8.8 85.7 ± 3.9 97.5 ± 2.5 
    # of SST 4.7 ± 0.7 4.5 ± 1.7 4.9 ± .4 6.1 ± 1.4 
    % w/SST+Synaptophysin 76.7 ±14.5 76.7 ±14.5 81.3 ± 5.3 80.0 ± 10.8 
    # of SST+Synaptophysin 3.13 ± 0.63 2.6 ± 0.4 3.5 ± 0.5 3.1 ± 0.1 




Table 6: Total number of synaptic contacts on to GnRH and NKB cells 
 Anestrus Luteal Early Follicular Surge 
GnRH     
    POA 7.9 ± 1.3ab 7.32 ± 0.3 a 8.6 ± 0.7 ab 10.32 ± 0.7 b  
    MBH 6.4 ± 0.4 9.8 ± 1.2 7.7 ± 1.3 9.9 ± 1.1 
NKB     
   Middle ARC 5.9 ± 0.3 a 7.9 ± 0.1 ab 7.4 ± 0.5 ab 11.01 ± 1.5 b 
   Caudal ARC 10.3 ± 1.4 ab 10.9 ± 1.6 ab 10.3 ± 0.3 a 14.9 ± 1.2 b 





























































































































EVIDENCE THAT A SUBPOPULATION OF SOMATOSTATIN NEURONS IN THE 
OVINE VENTRAL MEDIAL NUCLEUS CONTAIN NEURONAL NITRIC OXIDE 




Richard B.  McCosh, Michelle N. Bedenbaugh, Katrina Porter, Justin A. Lopez, Steven L. 
Hardy, Stanley M. Hileman, and Robert L. Goodman. 
Department of Physiology and Pharmacology (R.B.M., M.N.B., K.P., J.A.L., S.L.H., S.M.H., 







 Surge secretion of luteinizing hormone (LH) is necessary for ovulation and therefore 
fertility. Several lines of evidence support the hypothesis that somatostatin (SST) cells in the 
ventral medial nucleus (VMN) may be involved in the generation of the LH surge in sheep. 
However, neither a SST receptor 2 (SSTR2) agonist nor antagonist altered the timing or 
amplitude of the LH surge. In this study, we confirmed that SST cells in the VMN are activated 
during the LH surge using c-Fos as a marker for cellular activation. One explanation for the 
discrepancy between the observations of SST cell activation during the LH surge, but no effect 
of pharmacological manipulation of SSTR2, is that the cells that contain SST in the VMN also 
produce additional signaling molecules, such as nitric oxide. Immunohistochemistry was used to 
determine that a high percentage (70-80%) of these SST cells also contain neuronal nitric oxide 
synthase (nNOS). Furthermore, a greater percentage of the dual-labeled SST and nNOS cells 
were found to contain c-Fos during the LH surge compared to the early follicular phase. In 
contrast, the percentage of single labeled nNOS or SST cells that contained c-Fos did not differ 
between the LH surge and early follicular phase. Thus, we propose that this population of SST 
cells in the VMN also release nitric oxide and that this transmitter contributes to the generation 






Surge secretion of LH causes ovulation and is critical for fertility. The high and sustained 
secretion of GnRH and LH secretion that characterizes the LH surge are induced by elevated 
estradiol (E2). This stimulatory action of E2 is in contrast to typical inhibitory effects of E2 that 
suppress LH pulse amplitude throughout most of the ovarian cycle (1), and the two actions are 
likely mediated by alternative neural circuits within the hypothalamus (2). During the LH surge, 
approximately half of the GnRH neurons throughout the ovine hypothalamus express the 
common marker for cellular activation, c-Fos, indicating broad activation of GnRH cells (3). 
Because these cells do not contain estrogen receptor alpha (ERα) (4), neural afferents must 
convey this signal. In sheep, E2 administered into the ventral medial hypothalamus (VMN) and 
not into other areas, induces surge secretion of LH (5), indicating that the site of E2 positive 
feedback is in the mediobasal hypothalamus (MBH). Neural deafferentation studies have 
demonstrated a critical role for neural substrates in the rostral hypothalamus in order to induce an 
LH surge (6). Together these studies demonstrate that multiple hypothalamic regions are 
necessary for the detection and transmission of the LH surge. 
Several lines of evidence support a role for kisspeptin in the generation of the LH surge 
in sheep. First, kisspeptin cells in both the POA and ARC contain ERα (7). Second, kisspeptin 
cells in both the preoptic area (POA) and arcuate nucleus (ARC) express c-Fos during the LH 
surge (8–10). Third, icv kisspeptin infusion in anestrous ewes induced an LH surge (11). 
Additionally, the neuropeptide neurokinin B (NKB) is produced within the same neurons as 
kisspeptin in the ARC (12) and also contributes to the generation of the LH surge. 
Administration of the neurokinin 3 receptor (NK3R) agonist senktide causes surge-like secretion 
of LH (13,14) and administration of a NK3R antagonist (SB222200) into the retrochiasmatic 
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area (RCh) reduces the LH surge amplitude by ~40% (14). Similarly, icv administration of a 
kisspeptin receptor antagonist reduces the LH surge amplitude by ~50% (15), which indicates 
that other signaling molecules likely contribute to the generation of the full LH surge. 
Several lines of evidence support the hypothesis that the neuropeptide somatostatin (SST) 
may contribute to the generation of the LH surge. First, SST cells in the VMN contain ERα (16). 
Second, two studies have reported an increase in c-Fos expression in SST cells in the VMN 
during a naturally occurring LH surge (17) or in an estradiol benzoate induced LH surge (16) 
compared to the early follicular phase or oil treated controls, respectively. Finally, the SST 
receptor 2 agonist (octreotide) blunted the LH surge and prevented c-Fos expression within 
GnRH cells in rats (18). However, neither a SSTR2 agonist nor antagonist altered the timing or 
amplitude of an E2 induced LH surge in sheep (Chapter 2). One possible explanation for the 
discrepancy between the observations of SST cell activation during the LH surge, but no effect 
of pharmacological manipulation of SSTR2, is that the cells that contain SST in the VMN also 
contain another signaling molecule that does alter LH surge secretion. One such signaling 
molecule is nitric oxide produced by neuronal nitric oxide synthase (nNOS), which has recently 
been demonstrated to be critical for the LH surge in mice (19). 
The objective of this study was to further characterize the SST cells within the VMN 
throughout the estrous cycle and to specifically explore their role in the LH surge. Reports that 
SST cells are activated during LH surge secretion are unexpected because SST suppresses the 
firing of GnRH neurons in rodents (20,21) and inhibits GnRH secretion from hypothalamic 
explants (22), which is consistent with the generally inhibitory effects of SST reported 
throughout the body (23). In this study, we first sought to confirm that SST cells in the VMN are 
activated during the LH surge. Next we determined whether these cells also contain neuronal 
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nitric oxide synthase (nNOS). A high percentage of SST cells in the VMN did contain nNOS, so 
we determined whether the population of SST cells that contains nNOS is activated during the 
LH surge. Finally, because surge-like secretion of LH can also be induced by NK3R activation in 
sheep (13,14), we determined whether SST cells are activated following NK3R agonist 
administration. 
MATERIALS & METHODS 
 
Animals 
Multiparous mature ewes (>2years old) of mixed breeding were maintained in a light and 
temperature controlled research building. Lighting conditions were adjusted every other week to 
mimic local natural lighting conditions. Ewes were fed a maintenance ration of cubed alfalfa hay 
and had free access to water and mineral blocks. Breeding season experiments were done in 
October and November and anestrous studies were done in May and June. All procedures were 
approved by the West Virginia University Animal Care and Use Committee and were performed 
in accordance with the NIH guidelines for the care and use of research animals. 
Tissue collection and processing 
Tissue was collected as described previously (Chapter 1 and 2), briefly ewes were treated 
with heparin (20,000 U) 10 min before and at the time of euthanasia, which was performed with 
an overdose (8-16 mL, iv) of sodium pentobarbital (Euthasol, Patterson Veterinary, Bessemer, 
AL). The head was rapidly removed and perfused with 6L of 4% paraformaldehyde in 0.1M 
phosphate buffer (PB) with 0.1% NaNO3. A block of tissue including the hypothalamus and pre-
optic area (POA) was removed and stored overnight in the same paraformaldehyde solution at 
4°C. Tissue was then transferred to 20% sucrose in PB and maintained at 4°C. After sucrose 
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infiltration, tissue was frozen and 45μm-thick-coronal sections were cut with a microtome with a 
freezing stage and collected in 10 series (450μm apart) and stored at -20°C in cryoprotectant 
solution (24).  
Immunohistochemistry 
Immunohistochemistry was performed on free-floating sections at room temperature with 
mild agitation unless otherwise specified. Tissue was rinsed thoroughly in PB and stored at 4°C 
overnight. Tissue was then rinsed 12 times for at least 15 mins each in phosphate buffered saline 
(PBS; 0.1M PB with 0.9% saline). We used two approaches to enable the use of two antisera 
raised in the same species for immunohistochemistry in the same tissue section.  In experiment 1, 
one antiserum was visualized with nickel-enhanced 3,3’-diaminobenzidine (DAB) and the 
second with DAB alone, with intervening quenching steps for detection of antigens in different 
cellular compartments. In the other experiments, one antiserum was used at very low 
concentration and detected with tyramide amplification, a procedure that has been shown to 
prevent cross reactivity (25). Antisera used to detect NKB (26), nNOS (27) and SST (16) have 
been extensively used in sheep tissue and are described further in Table 1. 
Experiment 1: Are SST cells activated during the LH surge? 
Tissue collected from 15 ewes (5/group) killed during the luteal phase, early follicular 
phase (18 hrs after progesterone withdrawal) or during the LH surge (as described in Chapter 3) 
was used. For detection of SST and c-Fos, dual label immunohistochemistry was performed on 
one complete series of hemisections throughout the hypothalamus. Following the rinsing 
protocol described above, tissue was incubated in 1% H2O2 in PBS for 10 min, after which tissue 
was rinsed 4 times for 5 mins each in PBS (typical rinsing step). Tissue was incubated in 4% 
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normal goat serum (NGS; Jackson Immunoresearch, West Groove , PA)  in PBS containing 
0.04% triton X-100 (PBST) for 1 hr and then incubated in rabbit anti-c-Fos serum (dilution: 
1:3000 with 4% NGS in PBST; SC-253, Santa Cruz Biotechnology, Dallas, TX) for 17 hrs. 
Tissue was rinsed, and incubated sequentially in biotinylated goat anti-rabbit immunoglobulin 
(IgG; dilution: 1:500 in PBST with 4% NGS; BA-1000; Jackson Immunoreseach) for 1 hr, ABC-
elite (dilution 1:500 in PBS; Vector Lab Burlingame, CA) for 1hr and nickel enhanced DAB 
solution (10mg per 50mL PB with 2mL of 2% NiSO4 and 20μL of 30% H2O2 to produce a black 
reaction product, Sigma-Aldrich, Saint Louis, MO) for 10 min with intervening rinse steps. 
Tissue was rinsed in PB and placed into 1% H2O2 in PBS, rinsed and incubated in blocking 
solution containing 4% NGS in PBST for 1 hr, and was then incubated in rabbit anti-SST serum 
(dilution: 1:20,000 in PBST with 4% NGS, T4103, Peninsula Laboratories, San Carlos, CA) for 
17 hrs. Tissue was rinsed in PBS and incubated sequentially in biotinylated goat anti-rabbit IgG 
(dilution: 1:500 in PBST with 4% NGS), ABC-elite (dilution: 1:500 in PBS), and DAB (10mg 
per 50mL PB with 20μL of 30% H2O2 to produce a brown reaction product) for 10 min. Tissue 
was rinsed in PB and mounted onto superfrost slides (Fisher Scientific, Pittsburgh, PA), once 
dried, cover glass was applied with Eukitt (Fisher Scientific, Pittsburgh, PA) mounting media. 
The total number of SST cells and the percentage of SST cells that contained c-Fos was 
determined in 2-3 hemisections containing the VMN with a bright field microscope (VS-120, 
Olympus, Tokyo, Japan) with a 20x objective. All cell counts were made by a single observer 
blinded to treatment groups. Values were averaged per animal and compared among treatment 
groups by one-way ANOVA followed by Tukey’s Multiple Comparisons test. P < 0.05 was 




Experiment 2: Do SST cells contain nNOS? 
To determine whether SST cells in the VMN also contained nNOS, dual label 
immunohistochemistry was performed on tissue from 3 OVX ewes that were treated with E2 (3 
cm Silastic subcutaneous implant [inner diameter 0.34 cm, outer diameter 0.46 cm] Dow 
Corning Corp., Midland, MI containing E2) and progesterone (two progesterone containing 
intravaginal CIDRs; Zoetis, Parsippany, NJ). Tissue was collected 2 hrs after an icv injection of 
saline that did not alter LH secretion (data not shown). Following the rinsing and blocking 
protocol described above, tissue was incubated in rabbit anti-SST serum (dilution: 1:20,000 with 
4% NGS in PBST) for 17hrs. Tissue was rinsed with PBS and incubated sequentially in 
biotinylated goat anti-rabbit IgG (dilution: 1:500 in PBST with 4% NGS) for 1 hr, in ABC-elite 
(dilution: 1:500 in PBS; Vector Laboratories, Burlingame, CA) for 1hr, in biotinylated  tyramide  
(TSA; dilution: 1:250 in PBS with 1uL of 3% H2O2 per mL; Perkin Elmer, Bridgeville, PA) for 
10 min, and in Dylight 488 streptavidin (dilution: 1:200 in PBS; S32355; Invitrogen, Carlsbad, 
CA) for 1 hr, with intervening rinsing steps. Tissue was then rinsed, incubated in 4% NGS in 
PBST for 1 hr and placed in rabbit anti-nNOS serum (dilution 1:1000; cat: 24287; Immunostar, 
Hudson, WI) with 4% NGS in PBST for 17 h. Tissue was rinsed and incubated with Alexa 555 
goat anti-rabbit IgG (dilution 1:200 with 4% NGS in PBST, A-21245, Invitrogen) for 1 hr each 
with intervening rinsing steps. Preadsorption of either antibody with the alternative immunogenic 
peptide (i.e. SST antibody with nNOS immunogenic peptide and vice versa) did not alter patterns 
or density of immunostaining (Figure 1). Similarly, omission of nNOS antiserum resulted in a 
lack of specific staining in that color channel and did not alter patterns or density of 
immunostaining for SST (Fig 1). 
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Cells that contained SST, nNOS or both were counted in a stitched image encompassing 
the MBH collected with a fluorescent microscope (VS-120, Olympus, Tokyo, Japan) in 2-3 
hemisections with a 20x objective following minor adjustments to brightness and contrast. 
Values were averaged per animal. Because this study was descriptive in nature, no statistical 
analyses were performed. Data are presented as mean ± SEM percent or average number of cells 
per hemisection. 
Experiment 3: Are nNOS cells activated during the LH surge? 
To determine whether the population of SST cells that expressed c-Fos during the LH 
surge also contained nNOS, triple label immunohistochemistry was performed on a subset of the 
tissue used in experiment 1 (mid LH surge, n=4 and early follicular phase n=4). Because all three 
antisera used previously were raised in rabbits, an alternative SST antiserum (rat x SST, 
Millipore, MAB354) (16) that required antigen retrieval was used. Two hemisections were 
incubated for 20 min at 80°C in unmasking solution (Vector Laboratories) then allowed to cool 
for 30 min and rinsed with PBS. Tissue was incubated in 1% H2O2 in PBS for 10 min, rinsed 
then incubated in 4% NGS in PBST for 1 hr followed by rabbit anti-c-Fos serum (dilution: 
1:3000 with 4% NGS in PBST) for 17 hrs. Tissue was rinsed, and incubated sequentially in 
biotinylated goat anti-rabbit IgG (dilution: 1:500 in PBST with 4% NGS) for 1 hr, ABC-elite 
(dilution 1:500 in PBS) for 1 hr, TSA (1:250 in PBS with 1uL of 3% H2O2 per mL; Perkin 
Elmer) for 10 min, and in Dylight 488 streptavidin (dilution: 1:200) for 1 hr, with intervening 
rinsing steps. Tissue was rinsed and incubated in 4% NGS in PBST for 1 hr and then placed in 
rabbit anti-nNOS (dilution 1:1000 with 4% NGS in PBST) and rat anti-SST (dilution: 1:200 with 
4%  NGS in PBST; cat: MAB354, Millipore, San Billerica, MA) for 17 hr. Tissue was rinsed and 
incubated with Alexa 555 goat anti-rat IgG (dilution 1:200 with 4% NGS in PBST, A-21434, 
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Invitrogen) and Alexa 647 goat anti-rabbit (dilution 1:200 with 4% NGS in PBST, A21245, 
Invitrogen) for 1 hr each with intervening rinsing steps. Tissue was mounted on superfrost slides 
and coversliped with gelvatol. 
Cells that contained SST, nNOS, c-Fos and any combination of these were counted in a 
stitched image encompassing the MBH collected with a fluorescent microscope (VS-120, 
Olympus, Tokyo, Japan) with a 20x objective following minor adjustments to brightness and 
contrast. All cell counts were made by a single observer blinded to treatment groups and used to 
calculate percentage of each cell type that contained c-Fos. Cytoplasmic staining was described 
as: dual-labeled SST and nNOS cells, all SST cells (regardless of whether nNOS-ir was present), 
all nNOS cells (regardless of whether SST-ir was present), SST only (SST-ir, but not nNOS-ir) 
and nNOS only (nNOS-ir, but not SST-ir).  Values were averaged per animal and compared 
between mid LH surge and early follicular phase with t-tests. P < 0.05 was considered 
statistically significant. Data are presented as mean ± SEM percent or average number of cells 
per hemisection. 
Experiment 4: Are SST cells activated during NK3R agonist induced LH surge like 
secretion? 
Dual-label immunohistochemistry was performed on tissue that had been collected for a 
previous study (14) 3 hrs after senktide-containing or blank implants was administered through 
chronic guide cannulae aimed at either the RCh or POA described previously (14,28). Briefly, 
Anestrous ewes received 18-gauge bilateral guide cannula just above the RCh at least 3 weeks 
before the experiment. Ewes received either a senktide- (Tocris, Minneapolis, MN) containing 
(n=4) or a blank implant (n=7) through both guide cannula into tissue and were euthanized 3hrs 
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later.  Durring the breeding season, ewes received 18-gauge bilateral guide cannula just above 
the POA at least 2 weeks before the experiment. Estrous cycles were synchronized with 
prostaglandin F2α (2 injections 5 mg each 3 hrs apart; Lutalyse, (Zoetis, Parsippany, NJ) and 
each ewe received 2 intravaginal progesterone containing CIDRs after the 2
nd
 injection, 7 days 
later CIDRs were removed and ewes received prostaglandin F2α again. Eighteen hours later 
(early follicular phase), ewes received either a senktide (Tocris, Minneapolis, MN) containing 
(n=4) or a blank implant (n=7) through the guide cannula as above and were euthanized 3 hrs 
later.  
For immunohistochemistry, tissue was incubated in 1% H2O2 in PBS for 10 min, rinsed, 
incubated in 4% NGS  in PBST for 1 hr and then incubated in rabbit anti-c-Fos serum (dilution: 
1:3000 with 4% NGS in PBST; Santa Cruz Biotechnology) for 17 hrs. Tissue was rinsed, and 
incubated sequentially in biotinylated goat anti-rabbit IgG (dilution: 1:500 in PBST with 4% 
NGS; BA-1000; Jackson Immunoreseach) for 1 hr, ABC-elite (dilution 1:500 in PBS; Vector 
Laboratories) for 1hr and nickel enhanced  DAB (10mg per 50mL PB with 2mL of 2% NiSO4 
and 20μL of 30% H2O2 to produce a black reaction product, Sigma-Aldrich) for 10 min with 
intervening rinse steps. Tissue was then rinsed in PB and placed into 1% H2O2 in PBS, rinsed 
and incubated in blocking solution containing 4% NGS in PBST for 1 hr, and was incubated in 
rabbit anti-SST serum (dilution: 1:20,000 in PBST with 4% NGS) for 1 hr. Tissue was rinsed in 
PBS and incubated sequentially in biotinylated goat anti-rabbit IgG (dilution: 1:500 in PBST 
with 4% NGS), ABC-elite (dilution: 1:500 in PBS), and DAB (10mg per 50mL PB with 20μL of 
30% H2O2 to produce a brown reaction product) for 10 min. Tissue was rinsed in PB and 
mounted onto superfrost slides, once dried, cover glass was applied with Eukitt mounting media. 
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The total number of SST cells and the percentage of SST cells that contained c-Fos was 
determined in 3 hemisections with a bright field microscope (Olympus AZ70, Tokyo, Japan) 
with a 20x objective. SST cells were counted in the ARC, VMN and ventral lateral aspect of the 
VMN (VL-VMN). The VL-VMN was defined as lateral to the medial edge of the fornix. All cell 
counts were made by a single observer blinded to treatment groups. Values were averaged per 
animal and analyzed with a t-test (senktide vs control) for animals treated in the POA and in the 
RCh separately. P < 0.05 was considered statistically significant. Data are presented as mean ± 
SEM percent or average number of cells per hemisection. 
RESULTS 
Experiment 1: Activation of SST cells throughout the estrous cycle 
As previously reported (17), a greater percentage of SST cells in the ventral lateral aspect 
of the VMN contained c-Fos in ewes killed during the LH surge than during the early follicular 
or luteal phase of the estrous cycle (Fig 2). There were no significant differences in the average 
number of SST cells per hemisection between treatment groups (luteal, 152.4 ± 37.2; early 
follicular, 180.3 ± 48.9; mid LH surge, 199.3 ± 16.4). 
Experiment 2: SST and nNOS colocalization within the VMN 
 A dense plexus of SST fiber-like staining was observed in the VMN as described 
previously (16,29,30). Numerous neuronal cell bodies were observed throughout the MBH with 
many SST cells in the ventral lateral aspect of the VMN. A large cluster of nNOS-ir neurons 
were also present in the ventral lateral aspect of the VMN, immediately lateral to the dense 
plexus of fiber-like SST staining (Fig 3, top row). Immunostaining with the nNOS antiserum 
produced well defined and very clear soma. Somatostatin-ir fibers and soma were evident 
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throughout the MBH, but few of them contained nNOS. Some of the SST-ir structures were 
approximately the size of soma, but based on shape, they were not unambiguous soma. Many of 
these structures were observed within nNOS-ir that did appear to be soma. Within the VMN 
(including the ventral medial aspect of the VMN) the majority of SST-ir neurons (81.7 ± 7.5%) 
also contained nNOS -ir, similarly 73.1 ± 2.5% of nNOS-ir neurons contained SST-ir (Fig 3, 
middle row).  
No colocalization of nNOS-ir and SST-ir cells was observed in the ARC, though few 
SST cells (<10 per hemisection) were observed in the ARC. Similarly, minimal colocalization of 
SST-ir and nNOS-ir fibers was observed in this nucleus (Fig 3, bottom row). 
Experiment 3: Activation of the nNOS and SST cells in the VMN during the LH surge 
The total number of c-Fos-ir nuclei was greater in animals during the surge (83.6 ± 13) 
than the early follicular phase (45.1 ± 7.8). There was a trend (P = 0.07) for an increase in the 
percentage of all SST-ir cells that contained c-Fos-ir during the LH surge compared to the early 
follicular phase (Table 2, Fig 4). Neither the percentage of all nNOS-ir cells, nNOS only-ir cells 
nor SST only-ir cells that contained c-Fos differed between the stage of cycle (Table 2). 
However, the percentage of dual-labeled (nNOS and SST) cells that contained c-Fos was 
significantly greater during the LH surge than the early follicular phase (Table 2). The number of 
unidentified c-Fos cells (c-Fos nuclei but no cytoplasmic staining for SST or nNOS) and the total 
number of any type of neurotransmitter-containing cell (SST, nNOS, SST and nNOS) did not 
differ between groups (data not shown). The percentage of cells that colocalized SST and nNOS 
was lower in this experiment than in experiment 2 (47.5 ± 5.8% of SST cells had nNOS, and 




Experiment 4: Activation of SST cells during NK3R agonist-induced LH surge-like 
secretion 
Administration of senktide into the RCh caused a surge-like increase in LH 
concentrations (14,28), but did not alter the mean number of SST cells per hemisection in the 
VMN (senktide, 35.11 ± 14.1; control 42.1 ± 22.3) , VL-VMN (senktide, 30.3 ± 11.5; control, 
40.0 ± 20.34) or the ARC (senktide, 6.7 ± 1.9; control, 7.8 ± 2.8). Similarly, the percentage of 
SST cells that contained c-Fos in either the VMN (senktide, 10.7 ± 2.6%; control, 16.8 ± 9.8%), 
VL-VMN (senktide, 26.9 ± 6.7; control, 14.1 ± 5.9%) or ARC (senktide, 7.8 ± 4.2%; control, 
30.8 ± 16.5%) did not differ between animals that received senktide-containing or blank 
implants.  
Administration of senktide into the POA caused a surge-like increase in LH 
concentrations (14,28), but did not alter the total number of SST cells in the VMN (32.4 ± 6.07 ; 
control, 58.1 ± 10.7), VL-VMN (senktide, 38.1 ± 2.62; control, 58.11 ± 10.65) or the ARC 
(senktide, 5.1 ± 0.8; control, 4.9 ± 0.9). However, senktide administration significantly reduced 
the percentage of SST-ir cells that contained c-Fos in the VL-VMN (senktide, 8.8 ± 2.6%; 
control, 23.3 ± 0.9%) and VMN (senktide, 10.23 ± 5.6%; control, 26.43 ± 3.1%), but not in the 
ARC (senktide, 21.9 ± 7.3; control, 34.4 ±7.1). 
DISCUSSION 
 
We have confirmed that SST cells in the VMN do express c-Fos during the LH surge and 
found that a portion of SST cells in the VMN also contain nNOS. Moreover, a greater percentage 
of dual-labeled SST and nNOS cells express c-Fos during the LH surge compared to the early 
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follicular phase, whereas neurons that contained nNOS or SST alone did not. However, when 
surge-like secretion of LH was induced via NK3R activation, c-Fos expression was not induced 
in SST cells in the MBH. 
 This is the first report of colocalization of nNOS and SST in the same population of 
neurons.  This finding is supported by previous reports that SST cells in the VMN contain ERα 
(16,31), that progesterone receptor and ERα are colocalized throughout the hypothalamus (32) 
and that progesterone receptor is contained within cells stained with NADPHd (a marker for 
nitric oxide synthase) (33). The colocalization of SST and nNOS within neurons that are 
activated during the LH surge raises the intriguing possibility that the previously identified SST 
cells (based on Fos expression) in the VMN do contribute to the LH surge, but use NO, rather 
than SST, to do so. In mice, nNOS knock-out animals are infertile (34), due to an inability to 
ovulate (35). This ovulatory defect is mediated in large part by the lack of an LH surge, though 
ovary defects may also be present (19). It is possible that cells in the ovine VMN containing both 
SST and nNOS are the source of nitric oxide that stimulates LH surge secretion, but no data are 
available on the effects of nitric oxide on LH surge secretion in sheep.  
 The location of the fiber projections of the dual-labeled SST nNOS cells in the VMN is 
not known. Projections from the VMN to the POA have been demonstrated with anterograde 
tract-tracing agents in the sheep (36), which raises the possibility that SST cells in the VMN 
project to the POA. In Chapter 3, we identified structural synapses between SST fibers and 
GnRH cells in the POA. The number of these synapses was increased during the LH surge. 
GnRH neurons in the POA receive close contacts from nNOS fibers in prepubertal lambs (27). It 
remains to be determined wether SST and nNOS are colocalized within the same fibers within 
the POA. If SST fibers also contain nNOS, then the SST synapses onto POA GnRH cells 
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identified in Chapter 3 may also contain nNOS. Though speculative, these distinct anatomical 
observations provide a testable hypothesis that a population of cells in the VMN that contain 
SST, nNOS, and ERα project to the POA, synapse onto GnRH neurons and release the gaseous 
neuro transmitter nitric oxide to facilitate LH surge secretion. These neurons could also act via 
kisspeptin cells in the POA or ARC that have also been implicated in the LH surge in ewes (8–
10). However the lack of colocalization of SST and nNOS in fibers in the ARC argues against an 
action via the kisspeptin neurons in this area. 
The population of SST, nNOS and c-FOS triple-labeled cells observed during the LH 
surge were clustered in the ventral lateral aspect of the VMN, ventral to the fornix.  The 
distribution of SST cells was similar when detected with either SST antibodies (rabbit x SST 
Peninsula, or rat x SST Millipore), however the total number of unambiguous cell soma staining 
was lower when detected with the Millipore antibody, possibly because antigen retrieval was 
used with this antibody. This reduced detection of SST soma likely contributes to the lower 
amount of colocalization between SST and nNOS cells in Experiment 3 than in Experiment 4, 
though there were also differences in endocrine status.  
 Neurokinin B and NK3R signaling are critical for fertility in humans (37). In sheep, 
administration of the NK3R agonist senktide into the POA or RCh caused surge-like secretion of 
LH (14,28). Several lines of evidence cited above support the possibility that SST may contribute 
to the LH surge, so we tested whether SST cells in the VMN express c-Fos during senktide 
induced LH surge-like secretion. A statistically significant decrease in the percentage SST cells 
that contained c-Fos was observed in animals that received senktide into the POA. The half-life 
of c-Fos protein has been estimated to be hours long (38), which makes the acute decrease in c-
Fos expression within SST neurons difficult to interpret. The clear lack of an increase in c-Fos in 
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SST cells when senktide was administered into either area indicates that SST cells in the VMN 
are likely not involved in senktide-induced LH secretion. Moreover, two lines of evidence 
suggest that endogenous NKB does not act in the POA to induce LH surge secretion. First, a 
NK3R antagonist administered to the POA did not alter the timing or amplitude of an E2 induced 
LH surge (14). Second, there was no change in the percent of NK3R cells in the POA that 
expressed c-Fos during the LH surge compared to the luteal or early follicular phase of the 
estrous cycle (McCosh et al., unpublished observations). Thus, surge-like secretion of LH caused 
by senktide administration to the POA likly reflects an experimental artifact and not an important 
endogenous action of NKB in this area. 
 In conclusion, a specific population of cells in the ventral lateral aspect of the VMN 
contains both SST and nNOS, and is activated during the LH surge in ewes. In contrast, cells that 
contain nNOS or SST alone are not more active (based on Fos expression) at this time. Thus, we 
propose that this population of SST cells in the VMN also release NO and that this transmitter 
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Figure 1: Representative immunohistochemistry controls (raw images). Top block: anti-SST (left 
column), nNOS antiserum preadsorbed with SST peptide (middle column), merged image (right 
column). Middle block: SST antiserum preadsorbed with nNOS immunogenic peptide (left 
column), anti-nNOS (middle column), merged image (right column). Lower block: anti-SST (left 
column), nNOS antiserum omitted (middle column), merged image (right column). Within each 
block, top row low magnification; bottom row, higher magnification. Bar = 50 µm 
Figure 2: Percent of SST immunoreactive cells in the VMN that contain c-Fos during the early 
follicular phase, luteal phase and mid LH surge. Bars with different letters differ, P <0.05. 
Figure 3: SST and nNOS immunoreactivity in the ovine mediobasal hypothalamus (Top row, 
l0w magnification, bar = 500 µm), VMN (middle row, arrows indicate neurons that contain both 
nNOS and SST, triangles denote single labeled SST (top) or nNOS (bottom), bar = 50 µm. 
Bottom row, ARC, bar = 50 µm. Left column, SST immunoreactivity (greyscale), middle 
column, nNOS immunoreactivity (greyscale). Right column, merge: SST (green) and nNOS 
(red). 
Figure 4: c-Fos, SST, and nNOS immunoreactivity in the VMN in an animal killed during the 
LH surge. Upper right, SST (red); upper left SST (red) and c-Fos (green); lower left, nNOS 
(magenta); lower right nNOS (magenta), SST (red) and c-Fos (green). Arrow indicates a dual-
labeled nNOS and SST cell with c-Fos, triangles indicate  dual labeled nNOS and SST cells 
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Table 2: Percentage of immunoreactive cells that contain c-Fos within the VMN 
% of cells with c-Fos Early 
follicular 
Mid LH surge Statistical 
comparison 
dual labeled SST + nNOS cells 3.9 ± 1.3 17.3 ± 0.3 P = 0.0096 
all SST-ir cells 10 ± 2.9 21.6 ± 4.1 P = 0.07 
all nNOS-ir cells 7.2 ± 2.3 15.8 ± 4.7 not significant 
SST only-ir cells 14.1 ± 4.0 24.6 ± 6.9 not significant 










































































































In work published before this dissertation, several lines of evidence supported the 
hypothesis that somatostatin (SST) is involved in the LH surge and that SST could inhibit 
episodic LH secretion.  However, these studies were either correlative in nature or examined the 
effects of exogenous SST. The preceding chapters describe pharmacological and 
neuroanatomical data collected to test the hypothesis that somatostatin acts in the hypothalamus 
to regulate LH secretion in sheep. These studies are the first to test the hypotheses that 
endogenous SST release contributes to the control of the LH surge and episodic LH secretion in 
any species. 
SOMATOSTATIN AND THE LH SURGE 
 
Several lines of correlative evidence described in previous chapters led to the hypothesis 
that somatostatin (SST) contributes to the LH surge, however neither a SST receptor 2 (SSTR2) 
agonist nor antagonist altered the timing or amplitude of the LH surge (Chapter 2). These 
findings led us to reject the hypothesis that SST acting via SSTR2 has a major role in surge 
secretion of LH. An important caveat to this interpretation is that treatment with drug may have 
altered the GnRH surge secretion, but not LH surge secretion. Although a surge of GnRH causes 
the LH surge (1,2), and the amplitudes of the GnRH and LH surge are correlated, GnRH is often 
secreted in excess of that necessary to induce an LH surge (3). Additionally, the duration of the 
GnRH surge is much longer than that of the LH surge (4). Therefore, treatments administered in 
Chapter 1 may have had minor effects on GnRH surge secretion but did not manifest in a change 
in LH surge secretion.  
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We used SSTR2- selective agonist, octreotide (5),  and competitive antagonist, 
CYN154806 (6,7), that have been demonstrated to be selective for human  and rodent SSTR2, 
but have not previously been tested in sheep. SSTR2 was selected as a target based on evidence 
that this receptor mediates the actions of SST in rodents (8,9) and that GnRH cells in the preoptic 
area (POA) of sheep contain SSTR2, but not the other SST receptor subtypes, as determined by 
immunohistochemistry in a preliminary report (10). These findings do not preclude the 
possibility of action at other receptors. In mice, an SSTR2 agonist was shown to be equally as 
effective at inhibiting GnRH cell firing as SST itself. This finding is good evidence that SSTR2 
is important but does not preclude the possibility that other receptors may be involved. In mice, 
SSTR2mRNA only (8) and in sheep only SSTR2 protein (10) was detected in POA GnRH cells. 
These anatomical findings support a role for SSTR2, however the lack of detection of a molecule 
does not prove its absence.  Furthermore, data presented in this dissertation support the 
hypothesis that SST acts via GnRH cells in the MBH and kisspeptin cells in the ARC although 
there is no information on which receptors they contain. 
The observation that SST cells within the ventral medial nucleus (VMN) also contain 
neuronal nitric oxide synthase (nNOS) raises the possibility that a different signaling molecule 
produced by the same cells may contribute to the LH surge (Chapter 4). Projections from the 
VMN to the POA have been demonstrated with anterograde tract-tracing agents in the sheep 
(11), which supports the possibility that SST cells in the VMN project to the POA. In Chapter 3, 
we identified structural synapses between SST fibers and GnRH cells in the POA. The number of 
these synapses was increased during the LH surge, possibly indicating increased transmission of 
neuromodulators. GnRH neurons in the POA also receive close contacts from  nNOS fibers in 
prepubertal lambs (12). Based on these two observations, we hypothesize that the SST synapses 
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onto GnRH neurons also contain nNOS. Though speculative, these distinct anatomical 
observations provide a testable hypothesis that a population of cells in the VMN that contain 
SST, nNOS, and estrogen receptor α project to the POA and synapse onto GnRH neurons to 
release the gaseous neurotransmitter nitric oxide (NO) to facilitate LH surge secretion. It is also 
possible that SST-nNOS fibers project onto POA kisspeptin cells that have also been implicated 
in surge secretion of LH in sheep (13,14). 
 Several experiments are needed to test the hypothesis that neurons in the VMN that 
express both SST and nNOS contribute to the generation of the LH surge. First, to determine if 
NO stimulates LH surge secretion in sheep, a nNOS inhibitor could be administered during the 
induction of the LH surge. Second, immunofluorescence could be used to determine whether 
fibers that contain SST and nNOS are in close apposition to GnRH neurons in the POA and 
increase during the LH surge. If these dual labeled fibers are present, retrograde tract tracing 
experiments could demonstrate the origin of these fibers (VMN if the present hypothesis is 
correct). If this SST/nNOS neural circuit exists, it may serve as a redundant mechanism for the 
generation of the LH surge that acts in concert with the NKB/kisspeptin system described in 
Chapters 1 and 4. 
SOMATOSTATIN AND PULSATILE LH SECRETION 
 
Experiments in Chapter 2 demonstrate that endogenous SST, acting at least partly 
through SSTR2, inhibits episodic LH secretion.  Furthermore, blockade of SSTR2 in ovary-intact 
ewes increased mean LH in both the breeding season and anestrus, whereas in ovariectomized 
(OVX) ewes, SSTR2 blockade increased LH pulse frequency only in anestrus. Together, these 
studies provide evidence that SST contributes to steroid-independent suppression of LH during 
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anestrus, and may also have a minor role in the inhibitory actions of ovarian steroids on LH 
secretion. 
Despite the observation of steroid-independent suppression of gonadotropin secretion in 
response to photoperiod over 30 years ago, we still know very little about possible mechanisms 
for this effect. The only other signaling molecule that has been implicated in steroid-independent 
suppression of LH during anestrus is serotonin. Serotonin receptor antagonists increase LH pulse 
frequency in OVX ewes in anestrus but not during the breeding season (15,16). Serotonin 
depletion during anestrus increased LH pulse frequency in OVX ewes but not in OVX ewes 
treated with estradiol (E2) (16). Similarly, a 5-HT2 receptor antagonist (cyprohetadine) did not 
alter LH pulse frequency in intact anestrous ewes (17). But in another study, cyprohetadine 
increased LH pulse frequency and mean LH in E2-treated OVX ewes during anestrus (18). Thus, 
inhibitory effects of serotonin have been consistently demonstrated in OVX ewes, but are only 
sometimes apparent in steroid-treated or intact ewes. Selective (ketanserin and methysergide) 
and non-selective (cyprohetadine) 5-HT receptor antagonists, as well as serotonin depletion, all 
increased LH pulse frequency, results that are consistent with action at the 5-HT2 receptors (19).  
Similar to the effects of serotonin receptor blockade, blockade of SSTR2 increased mean 
LH in intact ewes during both the breeding season and anestrus, though there are some 
differences between studies.  First, cyprohetadine increased LH pulse frequency in E2-treated 
OVX ewes acutely exposed to a stimulatory photoperiod, but before LH secretion had risen (18), 
whereas in the present study (Chapter 2, experiment 2), CYN did not alter LH pulse frequency in 
luteal phase ewes. Whether this is due to differential action of SST and serotonin neural systems 
or if this is due to the presence of progesterone, a potent inhibitor LH secretion (20,21), in our 
study (Chapter 2) is not known. Second, cyprohetadine increased LH pulse frequency in E2 
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treated OVX ewes in anestrus (18) whereas in the present study, CYN did not alter LH pulse 
frequency in intact anestrus ewes. One possible difference between these two studies is the 
endocrine status (OVX +E2 vs ovary-intact animals). Notably,  disruption of serotonin signaling 
failed to increase LH secretion in OVX+E anestrous ewes in other studies (16) and a stimulatory 
effect on pulse frequency in our study (chapter 2, experiment 2)  could have been masked by an 
unexpected high pulse frequency when intact anestrous ewes were treated with vehicle. 
Despite subtle differences in response to antagonists, SST and serotonin may interact in 
the ovine hypothalamus. The ovine MBH contains abundant serotonergic fiber innervation (22) 
and mRNA for 5-HT2  receptor (23), therefore serotonin may suppress LH secretion by activating 
SST neurons. This possibility would also be consistent with the theory that serotonin suppresses 
LH via an inhibitory interneuron since 5-HT2 receptor activation releases diacylglycerol and 
inositol triphosphate, resulting in increased protein kinase C activity and Ca
++
 influx, which are 
generally considered excitatory signaling events (24). Functional tests of this hypothetical neural 
system with pharmacological approaches will be difficult because it involves inhibiting an 
inhibitor. If the SST cells in the VMN contain 5-HT2 receptor, a 5-HT-saporin conjugate could 
be used to ablate SST cells to determine whether the stimulatory effects of 5HT2 receptor 
antagonists act via SST. However, this technique will ablate all cells with 5-HT2, which may 
include cells other than just SST cells, complicating the interpretation of results. Therefore the 
first step in determining the feasibility of this approach is a detailed description of 5-HT2 content 
within the VMN. Correlative evidence could be provided if serotonin receptor antagonist induces 
c-Fos in SST neurons. Anatomical evidence for this neural circuit could be demonstrated by 
showing serotonergic fibers in close apposition to SST neurons and the presence of 5-HT2 
receptor in SST neurons. 
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SITES OF ACTION FOR ENDOGENOUS SST 
 
Although inhibitory actions of exogenous SST have now been demonstrated in humans, 
rodents and sheep, the specific sites of action of this neurotransmitter remain to be determined.  
In humans, iv SST infusion (25) and subcutaneous injections of octreotide (26) suppressed LH 
secretion. However, these peripherally administered drugs likely act at the pituitary gland 
because SST (27), a SST analogue (28), or a SSTR2 agonist (26) blunted the increase in LH 
caused by GnRH or GnRH agonists. These results do not preclude the possibility that SST also 
acts in the human hypothalamus to regulate GnRH secretion as it likely does in sheep and 
rodents; however, this possibility has not been specifically tested. 
 In rodents, SST has been demonstrated to act in the hypothalamus. Electrophysiological 
experiments have shown that SST can potently inhibit GnRH cell firing in the POA (8,29). 
Furthermore, icv SSTR2 agonist administration blunted the LH surge and also prevented an 
increase in c-Fos within these GnRH cells (9). Thus, there is both in vitro and in vivo data for 
action of SST within the hypothalamus, and more specifically in the POA, of rodents.  
In sheep, icv administration of SST inhibited episodic LH secretion (30) and GnRH 
neurons within the POA contain SSTR2 (10), however little else was known about potential sites 
of SST action. Therefore, we administered the SSTR2 agonist and antagonist into the third 
ventricle because this approach has the advantage of testing a functional role for SST signaling 
without a priori information of sites of action. 
 Several lines of evidence reported here support the hypothesis that SST acts in the MBH 
to suppress pulsatile LH secretion. First, analysis of the radiographs of cannula placement in 
ewes for experiment 3 (intact, anestrus, Chapter 2) indicate that cannula placed closer to the 
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infundibular recess had a greater response to CYN injections. Second, CYN induced an increase 
in percentage of GnRH and kisspeptin cells that contained c-Fos only in the MBH. Moreover, we 
found that 23 ± 4% of GnRH cells in the MBH had SST synapses in anestrous ewes, which is 
strikingly similar to the 24 ± 5% of GnRH cells that contained c-Fos after SSTR2 antagonist 
administration during anestrus. Thus, SST may act directly on a subset of GnRH cells in the 
MBH to regulate pulsatile LH secretion.  
Another possibility is that SST acts on KNDy cells in the ARC. KNDy cells are so named 
because they contain three neuropeptides kisspeptin, NKB, and dynorphin and have been 
implicated in pulsatile LH secretion. In these experiments we used two different markers for this 
population of neurons: kisspeptin (Chapter 2) and NKB (Chapter 3). The switch in markers was 
necessitated by the unavailability kisspeptin antiserum for later experiments. However the high 
degree of colocalization of these peptides in sheep (31) indicates that both peptides are adequate 
markers of the same population of neurons. The majority of KNDy cells received SST synapses 
(Chapter 3), but there was a relatively modest increase in the percentage of kisspeptin cells (and 
only in the caudal ARC) that contained c-Fos after SSTR2 antagonist administration. 
There are several possible experimental approaches to clarify the sites of SST action in 
the regulation of episodic LH secretion.  A detailed description of SST receptor expression in the 
ovine hypothalamus could indicate possible sites of action. Specifically assessing SSTR2 
colocalization within KNDy cells would determine whether KNDy cells are a possible site of 
SST action. If SST does act via KNDy cells to suppress LH secretion, then administration of a 






In this work I have demonstrated that endogenous SST plays an important role in the 
steroid-independent actions of photoperiod to suppress LH pulse frequency, but does not 
contribute to the control of the LH surge. Under many physiological conditions, female fertility 
is dependent on adequate episodic LH secretion, which is regulated by steroid-dependent and 
steroid-independent mechanisms. Although steroid-dependent suppression of gonadotropin 
secretion is more dramatic than steroid-independent suppression of LH in sheep, steroid-
independent suppression of LH is evident and critical for prepubertal suppression of LH in 
agonadal monkey s (32,33) and children (34,35). The finding that SST contributes to steroid-
independent suppression of LH pulse frequency during anestrus raises the exciting possibility 
that SST may contribute to steroid-independent suppression of LH  in other contexts, such as 
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